Previous
Previous Product Image

European Society of Cardiology EuroHeartCare 2019

20 $
Next

European Society of Cardiology HFA Discoveries 2020

25 $
Next Product Image

European Society of Cardiology Heart Failure 2019

20 $

+ Include: 494 videos + 964 pdfs, size: 178 GB

+ Target Audience: cardiologist

Description

+ Include: 494 videos + 964 pdfs, size: 178 GB

+ Target Audience: cardiologist

+ Sample video: contact me for sample video

+ Topics:

‘Obesity Paradox’ in patients with chronic heart failure and comorbidity.pdf
18F-Flutemetamol PET MR imaging of cardiac amyloidosis.pdf
18F-Flutemetamol PET-MR imaging of cardiac amyloidosis.mp4
2-years follow-up of ‘Provisional-T’ stenting of Left Main Coronary Artery in patients with true bifurcation stenosis.pdf
A 39-year-old childbearing potential woman in lactation period suffering from STEMI.pdf
A case of a patient with chronic kidney disease and hyperkalemia how to optimise RAAS inhibitors.mp4
A case of a patient with chronic kidney disease and hyperkalemia how to optimise RAAS inhibitors.pdf
A case of a patient with heart failure and hypertension.mp4
A case of a patient with heart failure and hypertension.pdf
A case of a patient with heart failure, atrial fibrillation and wide QRS – indication for a CRT-D.mp4
A case of a patient with heart failure, atrial fibrillation and wide QRS – indication for a CRT-D.pdf
A case of a patient with myocardial revascularisation and heart failure.mp4
A case of a patient with myocardial revascularisation and heart failure.pdf
A case of a pregnant woman with heart failure.mp4
A case of a pregnant woman with heart failure.pdf
A case of arrhythmogenic right ventricular cardiomyopathy.pdf
A case of brachial arteriovenous fistula secondary to venipuncture.pdf
A case of cardiac fibroma.pdf
A case of cardiac sarcoidosis diagnosed after heart transplantation.mp4
A case of cardiac sarcoidosis diagnosed after heart transplantation.pdf
A case of cerebral emboli complicating infective endocarditis caused by Abiotrophia defectiva.pdf
A case of chemotherapy-induced heart failure.pdf
A case of infectious endocarditis associated with Laubry-Pezzi syndrome.pdf
A case of systemic lupus erythematosus myopericarditis.pdf
A cause of left ventricle dilatation and dysfunction which may benefit from aetiological therapy.pdf
A constructivist approach to teaching patients with heart failure. Results from an intervention study.pdf
A crosstalk between atrial fibrillation and heart failure.mp4
A crosstalk between atrial fibrillation and heart failure.pdf
A curious case of syncope in an implantable cardioverter defibrillator patient.pdf
A decline in physical activity precedes sustained ventricular arrhythmias in women.pdf
A disease of inflammatory co-morbidities!.mp4
A disease of inflammatory co-morbidities!.pdf
A disease of the cardiomyocytes.mp4
A disease of the cardiomyocytes.pdf
A first in human multi-center, open label, prospective study to evaluate the safety, usability and performance of the V-LAP system.mp4
A first in human multi-center, open label, prospective study to evaluate the safety, usability and performance of the V-LAP system.pdf
A long history of recurrent prosthetic mitral valve thrombosis due to hypereosinophilic syndrome.pdf
A low dose Pimobendan was observed to prolong the period until re-hospitalization for Japanese patients.pdf
A meta-analysis of rhythm versus rate control for atrial fibrillation in chronic heart failure.pdf
A multicenter brazilian cohort to optimize heart failure treatment using an organized multidisciplinary approach – Optimize Brazil.pdf
A multidisciplinary approach combining medical and supporting care.mp4
A multidisciplinary approach combining medical and supporting care.pdf
A multidisciplinary approach to the long-term follow-up.mp4
A multidisciplinary approach to the long-term follow-up.pdf
A mutant Thr95Ile ATTR cardiac amyloidosis with polyneuropathy.pdf
A new mutation causing arrhythmogenic right ventricular cardiomyopathy with atypical presentation.pdf
A novel approach to atrial fibrillation the HFA algorithm.mp4
A novel approach to atrial fibrillation the HFA algorithm.pdf
A novel peptide agonist of galanin receptors reduces doxorubicin-induced heart failure in rats.pdf
A patient on RAAS inhibitors with hyperkalemia.mp4
A patient on RAAS inhibitors with hyperkalemia.pdf
A patient with acute heart failure and pulmonary embolism.mp4
A patient with acute heart failure and pulmonary embolism.pdf
A rare and dangerous presentation of alcoholic cardiomyopathy.pdf
A rare case of heart failure with preserved ejection fraction in Erdheim Chester syndrome, at the crossroad.pdf
A rare case of Prader-Willi syndrome presenting with heart failure due to dilated cardiomyopathy.pdf
A registry-based algorithm to predict ejection fraction in electronic health records.pdf
A translational mouse model of HFpEF.mp4
A translational mouse model of HFpEF.pdf
Acetazolamide as a potent chloride-regaining diuretic its short- and long-term effects in cardiovascular patients.pdf
Activity and outcomes of a cardio-oncology service in a public hospital of Greece; a two-year experience.pdf
Activity of the Adrenomedullin system to personalize post-discharge treatment in acute heart failure.mp4
Activity of the Adrenomedullin system to personalize post-discharge treatment in acute heart failure.pdf
Acute cardiac failure and fatal arrythmia in severe respiratory infections.pdf
Acute changes in myocardial metabolism.mp4
Acute changes in myocardial metabolism.pdf
Acute decompensated heart failure therapy enriched with angiotensin-neprilysin inhibitor, a single-center real life experience.pdf
Acute heart failure congestion and perfusion status; impact of the clinical classification on in hospital and long term outcomes.mp4
Acute heart failure congestion and perfusion status; impact of the clinical classification on in hospital and long term outcomes.pdf
Acute heart failure in mexico. a comparison between euroheart failure survey ii versus a mexican tertiary centre.pdf
Acute heart failure in patient with cervical cancer.pdf
Acute heart failure in young male with body dysmorphic disorder heroin induced myocarditis.pdf
Acute heart failure.mp4
Acute heart failure.pdf
Acute intravenous infusion of the beta-3 adrenergic receptor antagonist APD418 improves left ventricular function in dogs.mp4
Acute intravenous infusion of the beta-3 adrenergic receptor antagonist APD418 improves left ventricular function in dogs.pdf
Acute ischemic stroke as the sole manifestation of reversible cardiac dysfunction in a patient with systemic lupus erithematous.pdf
Acute myocardial inflammation.mp4
Acute myocardial inflammation.pdf
Additional LV systolic functional recovery after PVC ablation in a peripartum cardiomyopathy patient.pdf
Addressing knowledge gaps ongoing research on iron deficiency in chronic and acute heart failure.mp4
Addressing knowledge gaps ongoing research on iron deficiency in chronic and acute heart failure.pdf
Adherence to therapy in patients with chronic heart failure.pdf
Adherence to therapy in patients with heart failure with mid-range ejection fraction a problem to solve.pdf
Advances in diagnostic strategies CMR, cardiac CT or biopsy.mp4
Advances in diagnostic strategies CMR, cardiac CT or biopsy.pdf
Advances in pathophysiology.mp4
Advances in pathophysiology.pdf
After initial improvement, left ventricular ejection fraction remains stable in long-term survivors with dilated cardiomyopathy.mp4
After initial improvement, left ventricular ejection fraction remains stable in long-term survivors with dilated cardiomyopathy.pdf
Air pollution on myocardial remodeling in acute phase of Chagas disease in experimental model.pdf
Alcohol septal ablation in a patient with hypertrophic obstructive cardiomyopathy due to Anderson-Fabry disease.mp4
Alcohol septal ablation in a patient with hypertrophic obstructive cardiomyopathy due to Anderson-Fabry disease.pdf
All about myofilaments!.mp4
All about myofilaments!.pdf
All patients with functional mitral regurgitation should receive transcatheter mitral valve repair PRO.mp4
All patients with functional mitral regurgitation shouldreceive transcatheter mitral valve repair CONTRA.mp4
All patients with functional mitral regurgitation shouldreceive transcatheter mitral valve repair CONTRA.pdf
All patients with functional mitral regurgitation shouldreceive transcatheter mitral valve repair Rebuttal.mp4
All patients with heart failure and Atrial fibrillation should receive catheter ablation CONTRA.mp4
All patients with heart failure and Atrial fibrillation should receive catheter ablation CONTRA.pdf
All patients with heart failure and Atrial fibrillation should receive catheter ablation PRO.mp4
All patients with heart failure and Atrial fibrillation should receive catheter ablation PRO.pdf
All patients with heart failure and Atrial fibrillation should receive catheter ablation Rebuttal.mp4
Allopurinol safety and efficacy in heart failure patients a systematic review.pdf
Alteration in acquired von willebrand factor with centrifugal or axial flow left ventricular assist devices.mp4
Alteration in acquired von willebrand factor with centrifugal or axial flow left ventricular assist devices.pdf
Altered number of apoptotic-modified endothelial cells originated micro vesicles predict phenotypes of heart failure.pdf
An analysis of right ventricular failure in isolated left ventricular noncompaction and idiopathic dilated cardiomyopathy.pdf
An evaluation of heart failure register reviews and virtual clinics 2016-2018.pdf
An interesting case of right middle and lower zone pneumonia vs infective endocarditis secondary to aortic root abscess.pdf
An unusual case of giant cell myocarditis managed with immunosuppression and left ventricular assist device.mp4
An unusual case of giant cell myocarditis managed with immunosuppression and left ventricular assist device.pdf
An unusual case of infective endocarditis with Staphylococcus warneri, presenting as heart failure.pdf
An unusual case of myocarditis.pdf
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in heart failure patients with mid-range.mp4
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in heart failure patients with mid-range.pdf
Angiotensin-converting enzyme inhibitors in acute coronary syndrome with mid-range ejection fraction.pdf
Anticoagulation sex-related differences.mp4
Anticoagulation sex-related differences.pdf
Apelin pathway.mp4
Apelin pathway.pdf
Application of artificial intelligence in heart failure.mp4
Application of artificial intelligence in heart failure.pdf
Are we optimizing medical therapy during a heart failure hospitalisation.pdf
Arterial stiffness and the autonomic nervous system function with different phenotypes of heart failure.pdf
Artificial intelligence for heart failure care.mp4
Artificial intelligence for heart failure care.pdf
Association AG polymorphism of a MTHFR gene in development of an ischemic stroke in patients with an arterial hypertension.pdf
Association between cardiovascular medication and readmission in heart failure patients.mp4
Association between cardiovascular medication and readmission in heart failure patients.pdf
Association between heart failure medication at discharge and heart failure readmission.pdf
Association between length of stay and mortality or readmission in patients with acute heart failure.pdf
Association of expression of steroid receptors with development of chemotherapy induced cardiotoxicity in Patients.pdf
Association of left atrial enlargement with heart failure and cardiovascular events after acute coronary syndromes.pdf
Association of loop diuretics use and dose with outcomes in outpatients with heart failure.pdf
Association of polymorphism of 9 chromosome in development of an ischemic stroke in patients with an arterial hypertension.pdf
Association of titin truncating variants with adverse course of HFrEF in patients with postinfarction cardiosclerosis.pdf
Asymptomatic underwater swimmer with pulmonary hypertension and dilatation of right heart chambers – true or false.pdf
Atrial fibrillation and heart failure with non reduced ejection fraction can biomarkers make the difference.pdf
Atrial fibrillation in Dutch chronic heart failure with reduced ejection fraction patients the CHECK-HF registry.pdf
Atrial fibrillation _ D Atar (Oslo,NO).mp4
Atrial fibrillation _ D Atar (Oslo,NO).pdf
Atrial fibrillation _ D Vinereanu (Bucharest,RO).mp4
Atrial fibrillation _ D Vinereanu (Bucharest,RO).pdf
Availability and accessibility to heart failure treatment in latin america.pdf
Bacterial infections as a mediator of ventricular assist device-induced HLA allosensitization.mp4
Bacterial infections as a mediator of ventricular assist device-induced HLA allosensitization.pdf
Baroreflex Activation Therapy in Patients with Heart Failure with a Reduced Ejection Fraction.mp4
Baroreflex Activation Therapy in Patients with Heart Failure with a Reduced Ejection Fraction.pdf
Basic and translational science.mp4
Basic and translational science.pdf
Benefits of full yogic breathing for patients with chronic heart failure.pdf
Betablockers ivabradine.mp4
Betablockers ivabradine.pdf
Big Health Data and artificial intelligence in heart failure.mp4
Big Health Data and artificial intelligence in heart failure.pdf
Biomarker guidance to start remote patient management in heart failure.mp4
Biomarker guidance to start remote patient management in heart failure.pdf
Biomarker-guided treatment myth or reality.mp4
Biomarker-guided treatment myth or reality.pdf
Biomarkers and imaging.mp4
Biomarkers and imaging.pdf
Biomarkers in risk-stratification and follow-up.mp4
Biomarkers in risk-stratification and follow-up.pdf
Biomarkers of iron status (transferrin saturation, serum ferritin) in the course of acute myocarditis.pdf
Biomarkers to evaluate congestion and response to therapy.mp4
Biomarkers to evaluate congestion and response to therapy.pdf
Biomarkers.mp4
Biomarkers.pdf
BIS equation of glomerular filtration rate in the prediction of hospitalization and mortality in older patients with heart failure.mp4
BIS equation of glomerular filtration rate in the prediction of hospitalization and mortality in older patients with heart failure.pdf
Can we prevent heart failure in cancer patients.mp4
Can we prevent heart failure in cancer patients.pdf
Cancer.mp4
Cancer.pdf
Cardiac acoustic biomarkers reflect disease status and cardiac functions in patients with acute decompensate heart failure.pdf
Cardiac contractility modulation (CCM) in HFrEF NYHA Class III patients.mp4
Cardiac contractility modulation (CCM) in HFrEF NYHA Class III patients.pdf
Cardiac contractility modulation in patients with heart failure with reduced ejection fraction.mp4
Cardiac contractility modulation in patients with heart failure with reduced ejection fraction.pdf
Cardiac magnetic resonance.mp4
Cardiac magnetic resonance.pdf
Cardiac output and cardiac index by echocardiography modalities versus thermodilution a comparative study.pdf
Cardiac rehabilitation for patients with a ventricular assist device.mp4
Cardiac rehabilitation for patients with a ventricular assist device.pdf
Cardiac Resynchronization Therapy (CRT) which patients and what are the results.mp4
Cardiac Resynchronization Therapy (CRT) which patients and what are the results.pdf
Cardio-Oncology – Where have we come from in the last 20 years.mp4
Cardio-Oncology – Where have we come from in the last 20 years.pdf
Cardiomyopathies due to primary myodystrophies in the russian cohort of patients.pdf
Cardioprotective regulation of the mitochondrial permeability transition pores induced by metabolic preconditioning.pdf
Cardiopulmonary exercise testing as a fundamental tool in the assessment of the functional class in treating sacubitril valsartan.pdf
Cardiorenal syndrome.mp4
Cardiorenal syndrome.pdf
Cardiotoxic drugs and heart failure.mp4
Cardiotoxic drugs and heart failure.pdf
Cardiovascular dysfunction associated with tyrosine kinase inhibitor use in patients with metastatic thyroid cancer.mp4
Cardiovascular dysfunction associated with tyrosine kinase inhibitor use in patients with metastatic thyroid cancer.pdf
Cardiovascular outcome trials of novel antidiabetic drugs a critical analysis.mp4
Cardiovascular outcome trials of novel antidiabetic drugs a critical analysis.pdf
Careful volume assessment appears to be the critical factor in achieving clinical trial dose of sacubitril valsartan in the community.pdf
Catecholaminergic stunning during the acute phase – Preclinical and clinical evidence.mp4
Catecholaminergic stunning during the acute phase – Preclinical and clinical evidence.pdf
Catestatin serum levels are inversely associated with adverse structural and hemodynamic profile among patients.pdf
Catheter ablation.mp4
Cerebral blood flow is lower in heart failure patients with reduced ejection fraction who have atrial fibrillation.pdf
Challenges in preventing sudden cardiac death. The importance of familial background, genetic profiling and follow-up in.mp4
Challenges in preventing sudden cardiac death. The importance of familial background, genetic profiling and follow-up in.pdf
Challenges in the management of patients with kidney dysfunction.mp4
Challenges in the management of patients with kidney dysfunction.pdf
Changes in plasma neprilysin levels after left ventricular assist device implantation and association of outcomes during 1-year.pdf
Changes in the causes of death in a heart failure unit in Spain along 17 years.pdf
Changing habits alcohol and tobacco.mp4
Changing habits alcohol and tobacco.pdf
Characteristics and management of post-acute coronary syndrome acute heart failure patients in indonesia.pdf
Characteristics of heart failure patients treated with sacubitril valsartan in the province of Quebec, Canada.pdf
Characteristics of LV left ventricular myocardium remodeling in patients with acute decompensated heart failure.pdf
Characterization of kidney function in a canine model of cardiorenal syndrome.pdf
Chemotherapy induced cardiotoxicity. The role of right ventricle.pdf
Chicken or egg A case of tako-tsubo cardiomyopathy and spontaneous coronary dissection.pdf
Chronic heart failure confers a higher risk of non-cardiovascular death in a patients with atrial fibrillation.pdf
Chronic heart failure in patients with systemic amyloidosis.pdf
Chronic heart failure.mp4
Chronic heart failure.pdf
Chronic pulmonary disease.mp4
Chronic pulmonary disease.pdf
Circulating sphingosine-1-phosphate as a non-invasive biomarker of heart transplant rejection.mp4
Circulating sphingosine-1-phosphate as a non-invasive biomarker of heart transplant rejection.pdf
Clinical and echocardiographic features in diabetic and non-diabetic patients with chronic heart failure.pdf
Clinical and echocardiographic phenotypes of patients with postinfarction cardiosclerosis.pdf
Clinical and prognostic correlates of volume time curve at cardiac magnetic resonance in patients with non-ischaemic.pdf
Clinical application of regenerative therapies lights and shadows.mp4
Clinical application of regenerative therapies lights and shadows.pdf
Clinical assessment and in-hospital monitoring.mp4
Clinical assessment and in-hospital monitoring.pdf
Clinical case of heart failure and atrial fibrillation due to long persistent migrated cava-filter in the right ventricle.pdf
Clinical case of multiple thrombi in amphetamine-associated cardiomyopathy.pdf
Clinical characteristics and long-term outcomes of patients with acute decompensated heart failure with mid-range ejection.pdf
Clinical characteristics and prognosis of heart failure with mid-range ejection fraction insights from a multi-centre.pdf
Clinical characteristics of heart failure patients admitted to internal medicine vs. cardiology units the VASCO study.pdf
Clinical characteristics of patients with acute heart failure with adverse reactions to anticoagulation.pdf
Clinical impact of acute kidney injury in patients with acute coronary syndrome.pdf
Clinical impact of new generation of prosthesis in aortic regurgitation after transcatheter aortic valve replacement.pdf
Clinical outcomes after renal replacement therapy in heart failure patients with cardiorenal syndrome and refractory congestion.pdf
Clinical outcomes and predictors of cancer therapy related cardiac dysfunction (CTRCD) in breast cancer patients on Trastuzumab.pdf
Clinical phenotype and outcomes.mp4
Clinical phenotype and outcomes.pdf
Clinical phenotypes of acute heart failure based on signs and symptoms of perfusion and congestion at emergency department.mp4
Clinical phenotypes of acute heart failure based on signs and symptoms of perfusion and congestion at emergency department.pdf
Clinical presentation vs. treatment strategies.mp4
Clinical presentation vs. treatment strategies.pdf
Clinical presentation, practice patterns and in-hospital mortality findings from the Kerala heart failure registry (KHFR) of 5789 patients.pdf
Clinical presentation.mp4
Clinical presentation.pdf
Clinical spectrum and outcome of advanced heart failure in hypertrophic cardiomyopathy.pdf
Clinical trajectories and risk assessment.mp4
Clinical trajectories and risk assessment.pdf
Clinical use of a atrial fibrillation detection device for screening in highrisk patients.pdf
Clinical usefulness of cystatin C in patients with acute heart failure implications for sarcopenia and cachexia.pdf
Clinical utility of the IMPACT score for mortality prediction after heart transplantation external validation study.mp4
Clinical utility of the IMPACT score for mortality prediction after heart transplantation external validation study.pdf
Clinical value of anti-fibrotic strategies.mp4
Clinical value of anti-fibrotic strategies.pdf
Clinical, echocardiographic and cost improvement after the onset with sacubitril-valsartan in mexican patients with heart failure.pdf
Clinical, echocardiographic and laboratory profile of dilated cardiomyopathy with and without atrial fibrillation.pdf
Clinics of myocarditis.mp4
Clinics of myocarditis.pdf
CMR in heart failure detecting inflammation and fibrosis.mp4
CMR in heart failure detecting inflammation and fibrosis.pdf
cmR Pulmonary transit time has additional prognostic value over cMR-RVEF and estimated systolic pulmonary artery pressure.pdf
Co-morbid conditions and their relationship with mortality in elderly heart failure patients.pdf
Co-morbid pathology in long-time prognosis in patients with chronic heart failure decompensation.pdf
Co-morbodities in HFpEF.mp4
Co-morbodities in HFpEF.pdf
Cognitive dysfunction.mp4
Cognitive dysfunction.pdf
Coincidence or connection cardiac sarcoidosis in a patient with multiple benign naevi on a background of suspected rare somatic mutation.pdf
Collaborating with a patient organisation to implement a physical activity intervention.pdf
Combination immunosuppressive therapy with prednisone and azathioprine for virus-negative inflammatory cardiomyopathy.pdf
Comorbidity burden can discriminate chronic heart failure with preserved and reduced but not with mid-range ejection fraction.pdf
Comparative analysis of the European Heart Failure Self-Care Behavior Scale and the Self-care of Heart Failure Index.pdf
Comparative effectiveness of CABG and PCI in patients with ischemic heart failure.mp4
Comparative effectiveness of CABG and PCI in patients with ischemic heart failure.pdf
Comparing predictive factors for mortality between elderly and non elderly patients after an event of acute decompensated heart failure.pdf
Comparison of baseline characteristics and outcomes in women versus men referred for advanced heart failure therapies.pdf
Comparison of clinical profile and outcomes of patients with acute dyspnea due to acute heart failure, pulmonary causes.pdf
Comparison of left ventricular function changes in inflammatory and non-inflammatory dilated cardiomyopathy.pdf
Comparison of serum selenium and thyroid hormones in patients with acute myocardial infarction, chronic heart failure.pdf
Compeering of predictive accuracy for 30, 90 and 365-day Heart Failure readmission assessed by impedance technique.mp4
Compeering of predictive accuracy for 30, 90 and 365-day Heart Failure readmission assessed by impedance technique.pdf
Complications after implants of cardiac electronic device in acute heart failure.pdf
Comprehensive approach to the outpatient management of patients with prosthetic heart valves.pdf
Comprehensive management of Korean HF Patients.mp4
Comprehensive management of Korean HF Patients.pdf
Concentric versus eccentric remodeling in heart failure with reduced ejection fraction.mp4
Concentric versus eccentric remodeling in heart failure with reduced ejection fraction.pdf
Conclusion and take home message – Guidelines in Daily Practice I Potassium binders.mp4
Conclusion and take home message – Guidelines in Daily Practice II heart failure and hypertension.mp4
Conclusion and take home message – Guidelines in Daily Practice III Myocardial revascularisation in heart failure.mp4
Conclusion and take home message – Guidelines in Daily Practice III Myocardial revascularisation in heart failure.pdf
Conclusion and take home message _ F Ruschitzka (Zurich,CH).mp4
Conclusion and take home message _ F Ruschitzka (Zurich,CH).pdf
Conclusion and take home message _ G Filippatos (Athens,GR).mp4
Conclusion and take home message _ G Filippatos (Athens,GR).pdf
Conclusion and take-home message _ A Coats (Warwickshire,GB).mp4
Conclusion and take-home message _ A Coats (Warwickshire,GB).pdf
Conclusion and take-home message _ B Bozkurt (Houston,US).mp4
Conclusion and take-home message _ B Bozkurt (Houston,US).pdf
Concomitant pericardial effusion predicts adverse outcomes in patients with acute myocarditis.pdf
Concurrent Initiation of Intra-aortic Balloon Pumping with Extracorporeal Membrane Oxygenation Reduced In-hospital Mortality.mp4
Concurrent Initiation of Intra-aortic Balloon Pumping with Extracorporeal Membrane Oxygenation Reduced In-hospital Mortality.pdf
Congestion monitoring.mp4
Congestion monitoring.pdf
Consequences of a revised heart allocation system on the cost effectiveness of cardiac transplantation in the united states.mp4
Consequences of a revised heart allocation system on the cost effectiveness of cardiac transplantation in the united states.pdf
Constrictive pericarditis a forgotten cause of heart failure.pdf
Continuous-flow ventricular assist device to small left ventricle Is it nightmare.mp4
Controversy of iron overload.mp4
Controversy of iron overload.pdf
Coronary artery disease in a systemic sclerosis sine scleroderma female patient.pdf
Correlation between the occurrence of cardiac arrhythmias and symptoms of heart failure in pregnant women with underweight.pdf
Correlation of endorgan function and bioimpedance measurement in patients with advanced heart failure.pdf
Crude mortality risk in dilated cardiomyopathy. Comparison of the utility of general heart failure mortality scales.mp4
Crude mortality risk in dilated cardiomyopathy. Comparison of the utility of general heart failure mortality scales.pdf
Cultural factors and power relations influencing willingness to follow self-care recommendation a qualitative study.pdf
Current characteristics of infective endocarditis in a developing country a prospective cohort study.pdf
Current evidence from clinical trials.mp4
Current evidence from clinical trials.pdf
Daily monitoring parameters of arterial stiffness and central aortic pressure in patients with ankylosing spondylitis.pdf
Daily monitoring pulse wave velocity and other indicators of arterial stiffness in hypertensive patients comorbid with chronic.pdf
Data from clinical trials.mp4
Data from clinical trials.pdf
Decongestive therapy.mp4
Decongestive therapy.pdf
Decreased left atrial reservoir function can predict new onset atrial fibrillation in patients with acute heart failure.pdf
Defining iron deficiency in acute heart failure preliminary results.pdf
Definition – risk assesment – outcomes.mp4
Definition – risk assesment – outcomes.pdf
Definition and clinical phenotypes.mp4
Definition and clinical phenotypes.pdf
Definition and diagnosis.mp4
Definition and diagnosis.pdf
Definition and diagnosis.The new HFA algorithm.mp4
Definition and diagnosis.The new HFA algorithm.pdf
Definition of myocardial electrical dissynchrony by noninvasive activation mapping in predicting response to cardiac.pdf
Delayed diagnosis of Idiopathic Pulmonary Hypertension in woman with heart failure.pdf
Depression.mp4
Depression.pdf
Determinant factors of plasma fibroblast growth factor 23 levels in patients with heart failure patients with reduced ejection fraction.pdf
Determinants and consequences of new acute kidney injury in acutely decompensated heart failure.pdf
Determinants and prognostic impact of intra-hospital worsening of renal function in acute heart failure.pdf
Determinants of non-pharmacological compliance in patients with heart failure.pdf
Determination of optimal energy needs, protein, fats and carbons in patients with obesity and chronic heart failure.pdf
Development and feasibility testing of an avatar-based education application for improving heart failure patients’ knowledge.mp4
Development and feasibility testing of an avatar-based education application for improving heart failure patients’ knowledge.pdf
Development of a co-designed written resource for carers of patients with heart failure.pdf
Devices and interventions.mp4
Devices and interventions.pdf
Diabetes and metabolic disorders.mp4
Diabetes and metabolic disorders.pdf
Diabetes increases long-term risk of new-onset heart failure and mortality in atrial fibrillation.pdf
Diabetes-related cardiomyopathy.mp4
Diabetes-related cardiomyopathy.pdf
Diagnosing kindey dysfunction biomarkers, imaging and more.mp4
Diagnosing kindey dysfunction biomarkers, imaging and more.pdf
Diagnostic pitfalls separating myocardial infarction from injury.mp4
Diagnostic pitfalls separating myocardial infarction from injury.pdf
Diastolic dysfunction and HFpEF characteristics are exacerbated with ageing in smoothelin-like 1 (SMTNL1)-deficient mice.mp4
Diastolic dysfunction and HFpEF characteristics are exacerbated with ageing in smoothelin-like 1 (SMTNL1)-deficient mice.pdf
Differences in circulating cardiac biomarkers between immunoglobulin light-chain and transthyretin cardiac amyloidosis.mp4
Differences in circulating cardiac biomarkers between immunoglobulin light-chain and transthyretin cardiac amyloidosis.pdf
Differential diagnosis of stress induced cardiomyopathy from anterior myocardial infarction with changing pattern.pdf
Difficult diagnosis of co-existence of constrictive pericarditis and cardiomyopathy due to rheumatoid arthritis.pdf
Dilated cardiomyopathy what’s new.mp4
Dilated cardiomyopathy what’s new.pdf
Discussion – A first in human multi-center, open label, prospective study to evaluate the safety, usability and performance of the.mp4
Discussion – Activity of the Adrenomedullin system to personalize post-discharge treatment in acute heart failure.mp4
Discussion – Acute heart failure congestion and perfusion status; impact of the clinical classification on in hospital and long term.mp4
Discussion – Alteration in acquired von willebrand factor with centrifugal or axial flow left ventricular assist devices.mp4
Discussion – AMBER.mp4
Discussion – Baroreflex Activation Therapy in Patients with Heart Failure with a Reduced Ejection Fraction.mp4
Discussion – Biomarker guidance to start remote patient management in heart failure.mp4
Discussion – Cardiac contractility modulation (CCM) in HFrEF NYHA Class III patients.mp4
Discussion – Clinical phenotypes of acute heart failure based on signs and symptoms of perfusion and congestion at emergency.mp4
Discussion – Clinical presentation, management and 6-month outcome of women diagnosed with PPCM from.mp4
Discussion – COAPT.mp4
Discussion – COMMANDER-HF.mp4
Discussion – Comparative effectiveness of CABG and PCI in patients with ischemic heart failure.mp4
Discussion – First in human experience with direct sodium removal using a zero sodium peritoneal solution.mp4
Discussion – Furosemide Withdrawal in Stable Chronic Outpatients with Heart Failure a Double-blind, Multicenter, Randomized Trial.mp4
Discussion – IMPULSE-HF.mp4
Discussion – PARADIGM-HF.mp4
Discussion – PHARM-CHF.mp4
Discussion – PREFER.mp4
Discussion – REPORT-HF.mp4
Discussion – Safety and Efficacy of 24-hour Istaroxime Infusion in Patients Hospitalized for Acute Decompensated Heart Failure.mp4
Discussion -TARGET-1 and TARGET-2.mp4
Discussion.mp4
Disparity in care for device therapy in Europe.mp4
Disparity in care for device therapy in Europe.pdf
Distilling the clinical evidence behind the WCD – What have clinical trials and registries told us.mp4
Distilling the clinical evidence behind the WCD – What have clinical trials and registries told us.pdf
Diuretic adjustment algorithm and nonpharmacologic management in patients with heart failure reduce readmission.mp4
Diuretic adjustment algorithm and nonpharmacologic management in patients with heart failure reduce readmission.pdf
Diuretic dose and worsening renal failure in acute heart failure. DOSE-AHF in real life.pdf
Diuretic efficacy as a prognostic marker in patients admitted for heart failure.pdf
Diuretic resistance.mp4
Diuretic resistance.pdf
Do we equally treat women and men with heart failure.mp4
Do we equally treat women and men with heart failure.pdf
Do women with heart failure get the best treatment possible.pdf
Does metabolic syndrome influence right ventricular diastolic function in patients with preserved left ventricular systolic function.pdf
Donor age in heart transplantation results and controversies.pdf
Donor-recipient size-mismatching by predicted heart mass and survival after heart transplantation.mp4
Donor-recipient size-mismatching by predicted heart mass and survival after heart transplantation.pdf
Double trouble when a thrombus save your life.mp4
Double trouble when a thrombus save your life.pdf
Doxorubicin-induced cardiomyopathy gene variant TRPC6 as therapeutic target.mp4
Doxorubicin-induced cardiomyopathy gene variant TRPC6 as therapeutic target.pdf
Drugs targeting cardiac metabolism.mp4
Drugs targeting cardiac metabolism.pdf
Dynamics of functional condition in patients with NSTEMI depending from hospital treatment strategy.pdf
Dynamics of left ventricular ejection fraction in patients with stable coronary artery disease after coronary artery bypass grafting.pdf
Dynamics of mechanical dyssynchrony in patients with superresponse to cardiac resynchronisation therapy at a long-term follow-up.pdf
Dyspnea, beyond LV ejection fraction.mp4
Dyspnea, beyond LV ejection fraction.pdf
Early detection of cardio-toxicity the role of biomarkers.mp4
Early detection of cardio-toxicity the role of biomarkers.pdf
Early detection of cardio-toxicity the role of imaging.mp4
Early detection of cardio-toxicity the role of imaging.pdf
Early detection of cardiotoxicity in breast cancer patients red flags according to a traffic lights.pdf
Early detection of hTTR cardiac amyloidosis with bone DPD scintigraphy in a patient with a rare transthyretin mutation.mp4
Early detection of hTTR cardiac amyloidosis with bone DPD scintigraphy in a patient with a rare transthyretin mutation.pdf
Early heart remodeling in type 1 diabetes patients possible phenotype.mp4
Early heart remodeling in type 1 diabetes patients possible phenotypes.pdf
Early identification and prognosis of tachy-induced cardiomyopathy.mp4
Early identification and prognosis of tachy-induced cardiomyopathy.pdf
Early left ventricular reverse remodeling after sacubitril-valsartan treatment. Subanalysis of SAVE-RLife study.pdf
Early management.mp4
Early management.pdf
Early prediction of cardiac resynchronization therapy response by non-invasive electrocardiogram markers.pdf
Early reevaluation after acute heart failure experience from a dedicated clinic.pdf
Early urinary sodium as an early marker of diuretic resistance.pdf
Echocardiographic assessment emerging concepts.mp4
Echocardiographic assessment emerging concepts.pdf
Echocardiographic assessment of right ventricle function in HIV-infected patients during 1 year follow up.pdf
Echocardiographic assessment of treating patients with chronic heart failure with mid-range ejection fraction by external.pdf
Echocardiographic deformation imaging improves assessment of structural disease progression in arrhythmogenic cardiomyopathy.pdf
Echocardiographic differences between early- and late anthracycline-induced cardiotoxicity reveals a distinct cardiomyopathy.pdf
Echocardiographic features of ultra-elderly heart failure patients in Japan.pdf
Echocardiography.mp4
Echocardiography.pdf
Edge-to-edge percutaneous mitral repair for functional ischemic and non-ischemic mitral regurgitation.pdf
Effect of empagliflozin on hydroelectrolytic balance in patients with heart failure with reduced ejection fraction.pdf
Effect of sacubitril valsartan in real-world patients in South London.pdf
Effect of SGLT2 inhibitor on cardiac function in diabetic patients with or without heart failure an echocardiographic study.mp4
Effect of SGLT2 inhibitor on cardiac function in diabetic patients with or without heart failure an echocardiographic study.pdf
Effective and safe decongestion using the Reprieve-System in patients with acute heart failure.mp4
Effective and safe decongestion using the Reprieve-System in patients with acute heart failure.pdf
Effects of combined uptitration of ACE-inhibitors and beta-blockers in heart failure with reduced ejection fraction.mp4
Effects of combined uptitration of ACE-inhibitors and beta-blockers in heart failure with reduced ejection fraction.pdf
Effects of empagliflozin on exercise capacity and LV diastolic function in HFpEF and type-2 diabetes mellitus.pdf
Effects of perindopril on levels of endothelial dysfunction biomarkers in chronic heart failure patients with mid-range ejection.pdf
Effects of phosphodiesterase-5A inhibition on right ventricular cardiomyocyte function in diabetic cardiomyopathy.pdf
Effects of sacubitril valsartan on cardiac performance and exercise capacity.pdf
Effects of sacubitril valsartan on real-world patients with heart failure due to non-ischemic cardiomyopathy.pdf
Effects of statins on major adverse cardiovascular events in patients with ischemic chronic heart failure with reduced.pdf
Effects of sympathetic modulation by renal denervation in patients with heart failure and preserved ejection fraction.pdf
EFFICACY OF CARDIAC RESYNCHRONIZATION THERAPY AT SEVERE CHRONIC HEART FAILURE.pdf
Efficacy, safety and cost of comprehensive versus standard remote monitoring of patients with cardiac resynchronisation therapy.pdf
Efficiency of plasma exchange in patients with immune mediated dilated cardiomyopathy and arrhythmias.pdf
Elamipretide, to block mitochondrial dysfunction.pdf
Electrical instability and arrhythmias.mp4
Electrical instability and arrhythmias.pdf
Electrocardiography and echocardiography dyssynchrony correlation with left ventricular function in long term permanent.pdf
Eligibility for EMPEROR trials in a real-world heart failure population data from the Swedish heart failure registry.mp4
Eligibility for EMPEROR trials in a real-world heart failure population data from the Swedish heart failure registry.pdf
Empagliflozin in heart failure beyond clinical endpoints.pdf
Empaglifozin has cardioprotective and anti-inflammatory effects in mice during doxorubicin treatment.mp4
Empaglifozin has cardioprotective and anti-inflammatory effects in mice during doxorubicin treatment.pdf
Endomyocardial biopsy indications and risk.mp4
Endomyocardial biopsy indications and risk.pdf
Endomyocardial biopsy research application and future perspectives.mp4
Endomyocardial biopsy research application and future perspectives.pdf
Endothelial dysfunction common to heart failure and oncology – Discussion.mp4
Endovascular treatment of ischemic heart disease in patients with blood cancer.pdf
Ensuring the ‘safety’ of cancer octogenarian patients with comorbid chronic heart failure during non-cardiac operations.pdf
Establishing the first pharmacist-led heart failure medication optimization clinic in the middle east gulf region.pdf
Etiology of dilated cardiomyopathy as the leading predictor of efficiency of implantable cardioverter-defibrillators.pdf
Evaluation of creatinine based methods for estimating glomerular filtration rate in heart failure.mp4
Evaluation of creatinine based methods for estimating glomerular filtration rate in heart failure.pdf
Evaluation of left ventricle dysfunction and endothelin-1 level in arterial hypertension of renal genesis under influence of therapy.pdf
Evaluation of malnutrition using 6 screening tools in patients with chronic heart failure.pdf
Evaluation of the effectiveness of lisinicore and losartan in patients with chronic heart failure.pdf
Evaluation of the predictive capabilites of LV wall motion pattern and other strain characteristics in LV noncompaction patients.pdf
Evolution of death due to cancer in heart failure ambulatory patients during 17 years follow-up.pdf
Evolution of diastolic dysfunction of patients with acquired heart diseases in the postoperative period.pdf
Evolution of level of evidence c recommendations in European Society of Cardiology clinical practice guidelines on heart failure.pdf
Evolution of low risk natriuretic peptide to higher risk – Do we have a phenotype.mp4
Evolution of low risk natriuretic peptide to higher risk – Do we have a phenotype.pdf
Ex vivo allograft perfusion for heart transplantation single centre experience.pdf
Exercice what is enough and how much is too much.mp4
Exercice what is enough and how much is too much.pdf
Exercise capacity is negatively associated with cerebral white matter hyperintensity in elderly patients with heart failure.pdf
Exercise training in heart failure patients involvement level, motivation, barriers, and beliefs.pdf
Expanding the phenotype of loss-of-function mutations in the PPP1R13L gene causing paediatric dilated cardiomyopathy.pdf
Extent of late gadolinium enhancement was associated with re-worsening left ventricular ejection fraction in patients.mp4
Extent of late gadolinium enhancement was associated with re-worsening left ventricular ejection fraction in patients.pdf
Extracorporeal support life support. Insights form ventricular support with ecmo, levitronix and heartmate 3 in a patient.pdf
Exudative-constrictive pericarditis in association with arthritis toracoscopic biopsy as the only way to diagnosis and treatment.pdf
Fabry disease.mp4
Fabry disease.pdf
Factors influencing guideline-led prescribing to heart failure patients in an Egyptian critical care setting.pdf
Factors that influence Heart Failure treatment titration in a Heart Failure Unit.pdf
FE- IRON (First Ever Irish heart failure nurses group Review On implementation of ESC iroN guideline in Ireland).pdf
Feasibility of heart transplant in a distant insular population accessibility and outcomes in patients from the Canary Islands.pdf
Features emotional status at patient with ischemic heart disease and chronic heart failure and different types of left.pdf
Features heart rate variability at patients with ischemic heart disease, arterial hypertension and left ventricle hypertrophy.pdf
Feeling powerless to deal with thirst in heart failure patients a qualitative study of health care providers.pdf
Fibrosis and inflammation.mp4
Fibrosis and inflammation.pdf
First in human experience with direct sodium removal using a zero sodium peritoneal solution.mp4
First in human experience with direct sodium removal using a zero sodium peritoneal solution.pdf
Five year outcomes, India.pdf
Fluid removal therapies.mp4
Fluid removal therapies.pdf
Focused ultrasound.mp4
Focused ultrasound.pdf
Forecast of mOrtality Risk Early in the postCardiac Arrest Syndrome Therapy.mp4
Forecast of mOrtality Risk Early in the postCardiac Arrest Syndrome Therapy.pdf
Frailty evaluation in patients with chronic heart failure – A comparison of screening vs assessment tools.pdf
French team A peculiar cardiomyopathy.mp4
French team A peculiar cardiomyopathy.pdf
French team.pdf
Frequency of cardiac and non cardiac monocomorbidity in heart failure outpatients stratified by ejection fraction phenotype.pdf
From past to the future Heart Failure Registry III.mp4
From past to the future Heart Failure Registry III.pdf
Fulminant lymphocytic myocarditis with cardiogenic shock and multiorgan failure with complete recovery after percutaneous.mp4
Fulminant lymphocytic myocarditis with cardiogenic shock and multiorgan failure with complete recovery after percutaneous.pdf
Furosemide Withdrawal in Stable Chronic Outpatients with Heart Failure a Double-blind, Multicenter, Randomized Trial.mp4
Furosemide Withdrawal in Stable Chronic Outpatients with Heart Failure a Double-blind, Multicenter, Randomized Trial.pdf
Future perspectives in heart transplantation.mp4
Future perspectives in heart transplantation.pdf
Gaps in implementation and in knowledge.mp4
Gaps in implementation and in knowledge.pdf
Gender differences in plasma levels and prognostic value of NT-proBNP in chronic heart failure.pdf
Gender-related differences in chronic heart failure is there anything else to learn.pdf
Gender-related differences in patients with acute heart failure patient characteristics and clinical outcomes.pdf
Genes and acquired diseases together!.mp4
Genes and acquired diseases together!.pdf
Genetic risk prediction of atrial fibrillation in a contemporary heart failure cohort.mp4
Genetic risk prediction of atrial fibrillation in a contemporary heart failure cohort.pdf
Genome-wide gene expression analysis reveals pathomechanisms in patients with heart failure and preserved ejection fraction.mp4
Genome-wide gene expression analysis reveals pathomechanisms in patients with heart failure and preserved ejection fraction.pdf
German Team.pdf
Global longitudinal strain predicts future cardiovascular hospitalizations and death in patients with non-ischemic cardiomyopathy.mp4
Global longitudinal strain predicts future cardiovascular hospitalizations and death in patients with non-ischemic cardiomyopathy.pdf
Gonadectomy alters the effect of preconditioning training on the development of a hypoxic pulmonary hypertension in female rats.pdf
Greek Team Heart failure in vasculitis-related kidney disease Put the pieces of the puzzle together.mp4
Greek Team Heart failure in vasculitis-related kidney disease Put the pieces of the puzzle together.pdf
Greek Team.pdf
GRK2 regulates the endothelial responsiveness to bradykinin role in human angioedema.mp4
GRK2 regulates the endothelial responsiveness to bradykinin role in human angioedema.pdf
H2S donor (NaHS) improves diastolic function during aging by oxidative stress suppression and constitutive NO synthesis.pdf
Haemochromatosis an under-recognised and treatable cause of dilated cardiomyopathy.pdf
Hazardous effects of widespread inotrope use in acute heart failure patients.pdf
HCM Genetic diagnosis and Outcome.mp4
HCM Genetic diagnosis and Outcome.pdf
Heart failure and palliative care an integrated service for patients across hospital and community settings.pdf
Heart failure and tachycardiomyopathy in a patient taking ibrutinib a novel tyrosine kinase inhibitor.pdf
Heart failure as an acquired coronary fistula manifestation in the adulthood a rare case of a coronary arterial fistula.pdf
Heart failure day treatment centre (HFDTC), a novel service design.pdf
Heart failure diagnosis established and emerging biomakers.mp4
Heart failure diagnosis established and emerging biomakers.pdf
Heart failure digital coach pilot findings of an avatar style application to improve symptoms, self-care and knowledge of heart failure.pdf
Heart failure from cardiac ATTR-amyloidosis is a highly malignant disease.mp4
Heart failure from cardiac ATTR-amyloidosis is a highly malignant disease.pdf
Heart failure in a hypertrophic cardiomyopathy phenotype with an unknown genetic mutation a new aggressive variant.pdf
Heart failure in healthy young people with left bundle branch block long-term follow-u.pdf
Heart Failure in Internal Medicine and Cardiology same entity, different patterns.pdf
Heart failure in renal transplantation.mp4
Heart failure in renal transplantation.pdf
Heart failure matters website online support for patients.mp4
Heart failure matters website online support for patients.pdf
Heart failure outcomes in patients with diabetes with and without atrial fibrillation – data from the EMPA-REG OUTCOME study.mp4
Heart failure outcomes in patients with diabetes with and without atrial fibrillation – data from the EMPA-REG OUTCOME study.pdf
Heart failure patient’s journey clinical practices and attitudes regarding the diagnosis and management of heart failure.pdf
Heart failure patients with previous anterior myocardial infarction have a lower cerebral blood flow.pdf
Heart Failure Specialists of Tomorrow Awards.mp4
Heart Failure Specialists of Tomorrow Awards.pdf
Heart failure the great unknown.pdf
Heart failure whit preserved ejection fraction (HFpEF); a mexican cohort.pdf
Heart failure with mid-range ejection fraction a distinct entity or rather a transitional phase.pdf
Heart failure with mid-range ejection fraction in southern Brazil an eight year follow up cohort.pdf
Heart preservation with the organ care system for mechanical circulatory support recipients.mp4
Heart preservation with the organ care system for mechanical circulatory support recipients.pdf
Heart rate and rhythm in relation to quality of life in outpatients with heart failure.pdf
Heart transplant for acute heart failure in kearnes sayre syndrome.pdf
Heart transplantation in a child with Ebstein’s Anomaly and primary cardiomyopathy.pdf
Hemodynamic assesment do we need it.mp4
Hemodynamic assesment do we need it.pdf
HFA Atlas a comprehensive insight into European heart failure epidemiology.mp4
HFA Atlas a comprehensive insight into European heart failure epidemiology.pdf
HFA Philip Poole Wilson lecture Heart Failure Guidelines what is the alpha and what is the omega.mp4
HFA Philip Poole Wilson lecture Heart Failure Guidelines what is the alpha and what is the omega.pdf
HFWM – Title Single cell mechanics in failing heart role of microtubules and mitochondria re-arrangement.pdf
High degree AV block and ventricular septal rupture unmasking silent myocardial infarction.pdf
High frequency of left ventricular recovery in a national cohort of patients with advanced heart failure.pdf
High prevalence of progression of structural and functional abnormalities in a cohort at -risk for heart failure.mp4
High prevalence of progression of structural and functional abnormalities in a cohort at -risk for heart failure.pdf
High-intensity interval training alleviates consumptive coagulopathy in patients with heart failure.pdf
Higher daily oral furosemide requirement is a predictor for short term mortality in heart failure patients.pdf
Honorary Fellowship.mp4
Honorary Fellowship.pdf
How do race, education, and income adequacy affect self-care maintenance in adults with heart failure.pdf
How do we deliver Cardio-Oncology services in 2019.mp4
How do we deliver Cardio-Oncology services in 2019.pdf
How should cancer survivors be followed up after cancer treatment.mp4
How should cancer survivors be followed up after cancer treatment.pdf
How to achieve the optimisation we aim for.mp4
How to achieve the optimisation we aim for.pdf
How to adapt sex life.mp4
How to adapt sex life.pdf
How to assess frailty and fatigue.mp4
How to assess frailty and fatigue.pdf
How to assess iron status.mp4
How to assess iron status.pdf
How to implement the guidelines – Guidelines in Daily Practice I Potassium binders.mp4
How to implement the guidelines – Guidelines in Daily Practice I Potassium binders.pdf
How to implement the guidelines – Guidelines in Daily Practice II heart failure and hypertension.mp4
How to implement the guidelines – Guidelines in Daily Practice II heart failure and hypertension.pdf
How to implement the guidelines – Guidelines in Daily Practice III Myocardial revascularisation in heart failure.mp4
How to implement the guidelines – Guidelines in Daily Practice III Myocardial revascularisation in heart failure.pdf
How to implement the guidelines – Guidelines in Daily Practice IV patient with acute heart failure and pulmonary embolism.mp4
How to implement the guidelines – Guidelines in Daily Practice IV patient with acute heart failure and pulmonary embolism.pdf
How to implement the guidelines – Guidelines in Daily Practice V pregnancy and heart failure.mp4
How to implement the guidelines – Guidelines in Daily Practice V pregnancy and heart failure.pdf
How to increase the implant rates for class I indicated patients.mp4
How to increase the implant rates for class I indicated patients.pdf
How to set up a high quality registry.mp4
How to set up a high quality registry.pdf
How to start a cardio-oncology service.mp4
How to start a cardio-oncology service.pdf
Hybrid Imaging.mp4
Hybrid Imaging.pdf
Hyperkalaemia in patients with heart failure – Addressing the unmet medical need.mp4
Hyperkalaemia in patients with heart failure – Addressing the unmet medical need.pdf
Hypertrophic cardiomyopathy clinical phenotypes.mp4
Hypertrophic cardiomyopathy clinical phenotypes.pdf
Hypothyroidism versus hyperthyroidism in patients with heart failure. Which is worse.pdf
I am hurt, but I will be okay- An unusual case of reversible heart failure.pdf
ICD and heart transplantation in a child with ARVC.pdf
ICD-measured heart sounds and their correlation with echocardiographic indexes of systolic and diastolic function.pdf
Idarucizumab for urgent reversal of dabigatran before orthotopic heart transplantation.pdf
Identification of preclinical predictors of systolic dysfunction in the elderly population without a diagnosis of heart failure.pdf
Identifying patients home testing vs. laboratory testing.mp4
Identifying patients home testing vs. laboratory testing.pdf
Identifying urinary microRNAs for heart allograft rejection monitoring using small RNA sequencing – Pilot results.mp4
Identifying urinary microRNAs for heart allograft rejection monitoring using small RNA sequencing – Pilot results.pdf
Imaging inflammation or measuring markers to guide therapy.mp4
Imaging inflammation or measuring markers to guide therapy.pdf
Imaging of myocarditis.mp4
Imaging of myocarditis.pdf
Imaging.mp4
Imaging.pdf
Immediate and Long-term survival outcomes of Patients Admitted with Decompensated Heart Failure with underlying Valvular.pdf
Immediate recovery of atrial mechanical function after electrical cardioversion in patients with persistent atrial fibrillation.pdf
Immunotherapy associated cardiotoxicity pathophysiology, detection and treatment strategies.mp4
Immunotherapy associated cardiotoxicity pathophysiology, detection and treatment strategies.pdf
Impact of a clinical pharmacy service on heart failure guideline-led prescribing at discharge in an Egyptian critical care unit.pdf
Impact of anemia on long-term clinical outcome in patients with left ventricular systolic dysfunction after acute myocardial.pdf
Impact of beta blockers therapy on right ventricular function in heart failure patients with reduced ejection fraction.pdf
Impact of environmental factors on heart failure decompensations.mp4
Impact of environmental factors on heart failure decompensations.pdf
Impact of ICD implantation and PVI in patient with Isolated left ventricular apical hypoplasia accompanied.pdf
Impact of intracoronary injection of bone marrow on CMR derived myocardial strain 12 months after myocardial infarction.pdf
Impact of obesity and age on left atrial function in patients with paroxysmal atrial fibrillation undergoing catheter ablation.pdf
Impact of obesity on volume status in chronic heart failure.pdf
Impact of post-discharge statin withdrawal on long-term clinical outcome in patients with ischemic heart failure.pdf
Impact of recurrent heart failure hospitalizations on cardiovascular mortality in patients with heart failure in CPRD.pdf
Impact of sustained cardiac tachyarrhythmias recorded in coronary intensive care unit (cicu) on short and long-term mortality.pdf
Impact of sympathectomy upon myocardium.pdf
Impedance monitoring.mp4
Impedance monitoring.pdf
Implementation of the 2016 ESC guidelines for treatment of heart failure in patients after continuous flow LVAD implantation.pdf
Importance of serum sodium in ischemic heart failure with systolic dysfunction.pdf
Improvement of existing strategies to prevent heart failure after myocardial infarction a potential role for thrombopoietin.mp4
Improvement of existing strategies to prevent heart failure after myocardial infarction a potential role for thrombopoietin.pdf
Improvement of NT-proBNP and NYHA values in patients with HFrEF and Sacubitril Valsartan treatment.pdf
Improvement of right ventricular function with intraaortic balloon pump counterpulsation.mp4
Improvement of right ventricular function with intraaortic balloon pump counterpulsation.pdf
Improving a triangle of communication about palliative and end of life care.mp4
Improving a triangle of communication about palliative and end of life care.pdf
Improving diuresis and dropsy with elamipretide in advanced heart failure (IDDEA-HF); a multi-centre, double-blind.mp4
Improving diuresis and dropsy with elamipretide in advanced heart failure (IDDEA-HF); a multi-centre, double-blind.pdf
In-hospital initiation of sacubitril valsartan in stabilized patients with heart failure and reduced ejection fraction.pdf
Incidence of cancer in patients with heart failure with reduced ejection fraction a single-center long-term follow up study.pdf
Incidence of cardiotoxicity over time in patients with HER2-positive metastatic breast cancer on long term treatment.pdf
Incidence of vasoplegic syndrome after cardiac transplant in patients treated with Sacubitril Valsartan.pdf
Increased NT-proBNP levels most significantly predict 30-day mortality in admitted out-of hospital-cardiac-arrest (OHCA) patients.pdf
Indications for implantation.mp4
Indications for implantation.pdf
Inflammatory state and the development of low triiodothyronine syndrome in advanced heart failure.pdf
Influence of circulatory support devices on morbidity and mortality of cardiogenic shock after acute myocardial infarction.pdf
Influence of decompensated heart failure on cardiac acoustic biomarkers impact on early readmissions.pdf
Influence of gender on clinical results and predictor of long-term mortality after transcatheter aortic valve replacement.pdf
Influence of left ventricular ejection fraction category in patients with stenosis aortic undergoing with transcatheter aortic.pdf
Influence of the gender in response to phase ii of the cardiac rehabilitation program.pdf
Inhibition of apoptosis signal-regulating kinase 1 ameliorates cardiac dysfunction by reducing hypertrophy.pdf
Inhibition of cystathionine gamma-lyase can prevent cardiac dysfunction after focal cerebral ischemia.pdf
Initial blood pressure variability in patients with acute heart failure is associated with increased rehospitalization.pdf
Initial clinical experience with the first drug (sacubitril valsartan) in a new class -arni- in afro-caribbean patients.pdf
Initial experience of a nursing consultation in the uptitration of neurohumoral treatment in patientes with heart failure.pdf
Initiation of sacubitril valsartan in patients with de novo heart failure with reduced ejection fraction.pdf
Initiation of sacubitril-valsartan in patients with de novo heart failure with reduced ejection fraction.mp4
Innovative telemedicine – Using AI-analysed cardiac hemodynamic data.mp4
Innovative telemedicine – Using AI-analysed cardiac hemodynamic data.pdf
Inotropes risk and benefits.mp4
Inotropes risk and benefits.pdf
Inpatient versus outpatient introduction of angiotensin receptor neprilysin inhibitor in chronic heart failure patients.pdf
Interatrial shunt.mp4
Interatrial shunt.pdf
Intermittent infusions of levosimendan in advanced heart failure last but not least; a single-centre clinical experience.pdf
Interplay of stress regulatory transcription factors in human cardiac valvular disorders leading to heart failure and cross.pdf
Interventions and mechanical circulatory support.mp4
Interventions and mechanical circulatory support.pdf
Intravascular Ultrasound As An Effective Tool Of The Left Main Critical Lesion Detection In A LVEF-preserved Allograft.pdf
Intravenous iron.mp4
Intravenous iron.pdf
Introduction – An update on device technologies in heart failure.mp4
Introduction – An update on device technologies in heart failure.pdf
Introduction – Who should receive the wearable cardioverter defibrillator.mp4
Iron deficiency in heart failure what do we know in 2019.mp4
Iron deficiency in heart failure what do we know in 2019.pdf
Iron status and correlates of its deficiency in chronic heart failure patients in a west african cardiology practice.pdf
Iron therapy in heart failure with preserved vs depressed ejection fraction.pdf
Is diabetes a predictor of worse outcome in decompensated heart failure.pdf
Is dyspnoea a different sign in men and women with ACS.pdf
Is the obesity paradox also present in heart failure with mid-range ejection fraction.pdf
Is there a mortality weekend effect in cardiac transplantation for patients with Adult Congenital Heart Disease.pdf
Is there a mortality weekend effect in cardiac transplantation.pdf
It is the real deal right ventricular dysfunction is a common finding across different ejection fraction phenotypes in acutely.pdf
Key issues in diet, weight control.mp4
Key issues in diet, weight control.pdf
L-2-hydroxyglutarate dehydrogenase (L2HGDH) is a novel metabolic target protecting from cardiac hypertrophy and heart failure.mp4
L-2-hydroxyglutarate dehydrogenase (L2HGDH) is a novel metabolic target protecting from cardiac hypertrophy and heart failure.pdf
LA pressure reduction.mp4
LA pressure reduction.pdf
Lack of prognostic effect of N-terminal pro-brain natriuretic peptide levels in acute heart failure and functional severe tricuspid.pdf
Leadless Pacing.mp4
Leadless Pacing.pdf
Left atrial enlargement predicts 1-year mortality in patients with atrial fibrillation and heart failure.pdf
Left atrial remodeling in patients with mid-range ejection fraction heart failure with ischemic heart disease.pdf
Left ventricular assist devices which patients and what are the results.mp4
Left ventricular assist devices which patients and what are the results.pdf
Left ventricular diastolic dysfunction in patients with paroxysmal atrial fibrillation.pdf
Left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy assessed by cardiac magnetic resonance imaging.pdf
Left ventricular myocardial non-compaction associated with hypertrophic cardiomyopathy.pdf
Left ventricular non compaction.mp4
Left ventricular non compaction.pdf
Left ventricular non-compaction and coronary artery disease what’s causing systolic dysfunction a case report.pdf
Left ventricular systolic dysfunction in asymptomatic patients with diabetes mellitus type 1 is associated.pdf
Leptospirosis an unusual cause of multiorgan failure and severe cardiac involvement with impressively wide QRS complex.pdf
Lessons learned from registries.mp4
Lessons learned from registries.pdf
Levosemindan using in pediatric patients with end-stage heart failure single center experience.pdf
Limited diagnostic accuracy of the new ASE EACVI algorithm for heart failure with preserved ejection fraction (VEEDia-study I).pdf
Liver and gut disfunction.mp4
Liver and gut disfunction.pdf
Long term changes in the hearts of Takotsubo syndrome survivors.mp4
Long term changes in the hearts of Takotsubo syndrome survivors.pdf
Long term outcomes in asymptomatic patients with severe aortic stenosis.pdf
Long-term left ventricular ejection fraction trajectory in diabetic patients is there any difference.pdf
Long-term left ventricular ejection fraction trajectory in diabetic patients is there any difference.mp4
Long-term mechanical circulatory support indications and follow-up.mp4
Long-term mechanical circulatory support indications and follow-up.pdf
Long-term prognosis of dilated cardiomyopathy in women.pdf
Long-term prognostic impact of beta-blocker prescription during hospitalization for acute myocardial infarction.pdf
Long-term prognostic impact of post-discharge heart failure after ST-segment elevation myocardial infarction.pdf
Long-term results of coronary artery bypass surgery in patients with Q-myocardial infarction and postinfarction angina.pdf
Longitudinal changes in serum creatinine in patients with heart failure receiving oral anticoagulation for atrial fibrillation.pdf
Longitudinal Diastolic strain as predictor for systolic dysfunction among active breast cancer patients.mp4
Longitudinal Diastolic strain as predictor for systolic dysfunction among active breast cancer patients.pdf
Low flow aortic stenosis in heart failure. How to interpret.mp4
Low flow aortic stenosis in heart failure. How to interpret.pdf
Low heart rate at follow up predicts improvement of ejection fraction in a large-volume cohort of women with wearable.pdf
Low pulmonary artery pulsatility index is associated with adverse outcomes in patients with advanced heart failure.pdf
Low T3, it is not the same. Part II.pdf
Lung injury, a clinical issue among patients with acute heart failure.pdf
Lung Ultrasound Guided Treatment in Ambulatory Patients with Heart Failure a Randomized Controlled Clinical Trial (LUS-HF study).mp4
Lung Ultrasound Guided Treatment in Ambulatory Patients with Heart Failure a Randomized Controlled Clinical Trial (LUS-HF study).pdf
Lung ultrasound in acute heart failure prevalence of pulmonary congestion and associated short- and long-term outcomes.mp4
Lung ultrasound in acute heart failure prevalence of pulmonary congestion and associated short- and long-term outcomes.pdf
LUS-HF study – Discussion.mp4
LV global longitudinal strain as a predictor for LV reverse remodeling in dilated cardiomyopathy.pdf
LV only fusion pacing CRT without RV lead clinical and echocardiographic characteristics of super-response.pdf
LVAD-DT The final destination.pdf
Machine learning based risk stratification of patients undergoing cardiac resynchronization therapy.mp4
Machine learning based risk stratification of patients undergoing cardiac resynchronization therapy.pdf
Magnesium orotate for the treatment of heart failure in pregnant patients with unoperated atrial or ventricular septal defect.pdf
Malnutrition in patients undergoing tricuspid valve edge-to-edge repair incidence, clinical features and prognostic importance.pdf
Management of antithrombotic antiplatelet therapy in patients with aortic stenosis undergoing transcatheter aortic.pdf
Management of complications.mp4
Management of complications.pdf
Management of iron deficiency in clinical practice implementing the guidelines.mp4
Management of iron deficiency in clinical practice implementing the guidelines.pdf
Management of patients with advanced heart failure and type 2 pulmonary hypertension.pdf
Management _ A Lyon (London,GB).mp4
Management _ A Lyon (London,GB).pdf
Management _ L Cooper (Jacksonville,US).mp4
Management _ L Cooper (Jacksonville,US).pdf
Management _ M Metra (Brescia,IT).mp4
Management _ M Metra (Brescia,IT).pdf
Managing COPD in Heart Failure.mp4
Managing COPD in Heart Failure.pdf
Managing Heart Failure in COPD.mp4
Managing Heart Failure in COPD.pdf
Mechanical ventilation respiratory support.pdf
Mechanical ventilation-respiratory support.mp4
Mechanisms of disease and treatments.mp4
Mechanisms of disease and treatments.pdf
Medical devices and big data.mp4
Medical devices and big data.pdf
Medical management prospects and pitfalls.mp4
Medical management prospects and pitfalls.pdf
Medical therapy _ GMC Rosano (London,GB).mp4
Medical therapy _ GMC Rosano (London,GB).pdf
Medical therapy _ JT Parissis (Athens,GR).mp4
Medical therapy _ JT Parissis (Athens,GR).pdf
Medical treatment of octogenarians with chronic heart failure data from CHECK-HF.mp4
Medical treatment of octogenarians with chronic heart failure data from CHECK-HF.pdf
Medical treatment.mp4
Medical treatment.pdf
Medications profile post hospitalization for acute heart failure.mp4
Medications profile post hospitalization for acute heart failure.pdf
Menage a trois – Laboratory markers of myocardial injury, systemic inflammation, and thrombosis in patients.pdf
Metabolism and pharmacokinetic drug interaction profile of vericiguat, a soluble guanylate cyclase stimulator.pdf
Metformin reduces myocardial oxygen consumption and improves myocardial efficiency in pre-diabetic heart failure patients.mp4
Metformin reduces myocardial oxygen consumption and improves myocardial efficiency in pre-diabetic heart failure patients.pdf
Method of the logistic regression analysis in forecasting of development of atrial fibrillation.pdf
MicroRNAs expression in hypertrophic cardiomyopathy patients.pdf
MicroRNAs expression profile in advanced heart failure patients perspectives for risk stratification.pdf
Mihai Gheorghiade Lecture.mp4
Mihai Gheorghiade Lecture.pdf
Mineralocorticoid receptor antagonist.mp4
Mineralocorticoid receptor antagonist.pdf
Mineralocorticoid receptor antagonists.mp4
Mineralocorticoid receptor antagonists.pdf
MITRA-FR trial facts and perspectives.mp4
MITRA-FR trial facts and perspectives.pdf
Mitral insufficiency. When too late to intervene.mp4
Mitral insufficiency. When too late to intervene.pdf
Mitral insufficiency. Who is the right patient to send for intervention.mp4
Mitral insufficiency. Who is the right patient to send for intervention.pdf
Mitral valve interventions.mp4
Mitral valve interventions.pdf
Mobile applications for heart failure management.mp4
Mobile applications for heart failure management.pdf
Molecular and genetic markers a renin-angiotensin-aldosteron systems as predictors of development of a diastolic heart failure.pdf
Morning rise in blood pressure according to ambulatory blood pressure monitoring in patients with hypertension.pdf
Mortality risk factors in patients from a heart transplantation waiting list.pdf
Motivations and barriers towards physical activities in heart failure patients with focus on age differences.mp4
Motivations and barriers towards physical activities in heart failure patients with focus on age differences.pdf
Multicenter randomized clinical trial of the efficacy and safety of intravenous Quercetin in patients with acute.pdf
Multidisciplinary care for end-stage HF. How to improve care.pdf
Multiple patterns of left ventricular diastolic function and its determinants in cardiac amyloidosis.mp4
Multiple patterns of left ventricular diastolic function and its determinants in cardiac amyloidosis.pdf
Murine Experimental Autoimmune Myocarditis (EAM) is associated with LV hypertrophy but not with reduced LV systolic function.pdf
Music Entertainment -1.mp4
Music Entertainment -1.pdf
Music Entertainment -2.mp4
Music Entertainment -2.pdf
MYK-491, a novel cardiac myosin activator, increases cardiac contractility in healthy volunteers.pdf
Myocardial fibrosis and long-term outcome after septal myectomy in hypertrophic cardiomyopathy.pdf
Myocardial fibrosis new concepts.mp4
Myocardial fibrosis new concepts.pdf
Myocardial iron homeostasis and hepcidin expression in a rat model of chronic heart failure at different levels of dietary iron intake.pdf
Myocardial iron repletion and changes in left ventricular function.pdf
Myocardial perfusion disturbance in the development of chronic Chagas cardiomyopathy.pdf
Myocardial recovery update 2019.mp4
Myocardial revascularization strategies.mp4
Myocardial revascularization strategies.pdf
Myocarditis in Antisynthetase Syndrome an infrequent association.pdf
N-terminal pro-B-type natriuretic peptide in chronic heart failure The impact of sex across the ejection fraction spectrum.pdf
Nesfatin-1 activity in hypertensive obese patients changes with the duration of hypertension.pdf
Neuroendocrine inhibition in patients with heart failure and severe aortic stenosis undergoing TAVI.pdf
New approaches in personalized diagnose of patients with symptomatic obstructive hypertrophic cardiomyopathy optimize.pdf
New devices in heart failure.mp4
New devices in heart failure.pdf
New evidence on hyperkalaemia management in patients with heart failure, resistant hypertension _ I Pina (Detroit,US).mp4
New evidence on hyperkalaemia management in patients with heart failure, resistant hypertension _ I Pina (Detroit,US).pdf
New evidence on hyperkalaemia management in patients with heart failure, resistant hypertension _ P Rossignol (Vandoeuvre Les Nancy,FR).mp4
New evidence on hyperkalaemia management in patients with heart failure, resistant hypertension _ P Rossignol (Vandoeuvre Les Nancy,FR).pdf
New imaging methods in heart failure shifting paradigm.mp4
New imaging methods in heart failure shifting paradigm.pdf
New Imaging techniques in heart failure.mp4
New Imaging techniques in heart failure.pdf
New insights into the epidemiology.mp4
New insights into the epidemiology.pdf
New medical devices and applied data analytics.mp4
New medical devices and applied data analytics.pdf
Nitric oxide and kinins system plasma levels in patients with chronic Chagas heart disease and systemic arterial hypertension.pdf
Nitrosative stress drives HFpEF.mp4
Nitrosative stress drives HFpEF.pdf
Nitroxyl donors.mp4
Nitroxyl donors.pdf
Noninvasive diagnostic technique in ventricular tachyarrhythmias assessment in patients with coronary artery disease.pdf
Normal cardiac autonomic control in good CRT responders is not reliable predictor of future major ventricular arrhythmias.pdf
Novel biomarkers the missing link.mp4
Novel biomarkers the missing link.pdf
Novel devices The road ahead.mp4
Novel devices The road ahead.pdf
Novel therapeutic targets.mp4
NT-proBNP as a prognostic marker development of acute kidney injury in patients with acute decompensated heart failure.pdf
Nuclear imaging in the evaluation of ventricular dysfunction.mp4
Nuclear imaging in the evaluation of ventricular dysfunction.pdf
Numb Chin syndrome, intracardiac mass in right ventricle and pulmonary nodules as metastasis of diffuse large B-cell lymphoma.pdf
Nursing and telemedicine.mp4
Nursing and telemedicine.pdf
Obesity and diabetes impact on heart failure outcomes.mp4
Obesity and diabetes impact on heart failure outcomes.pdf
Observational study on the use of non antivitamin K anticoagulants in atrial fibrillation and deep vein thrombosis in the community.pdf
Off pump implantation of HeartMate III LVAD and closure of patent foramen ovale in patient with HIT.pdf
Off the record with Professor Magdi Yacoub.mp4
Off the record with Professor Magdi Yacoub.pdf
Old therapies of new fashion a better way to use diuretics and normal saline in acute decompensated heart failure.pdf
Omecaptiv.mp4
Omecaptiv.pdf
On mid-term, had mid-range ejection fraction heart failure the same prognosis with reduced ejection fraction heart failure.pdf
Ongoing clinical trials in HFPEF.mp4
Ongoing clinical trials in HFPEF.pdf
Opportunity or futility TAVI in elderly patients with depressed ejection fraction and severe aortic stenosis.pdf
Optimal administration timing of thiazide diuretics for sequential nephron blockade in cardiovascular patients receiving loop diuretics.pdf
Optimal endpoints for decongestion.mp4
Optimal endpoints for decongestion.pdf
Optimal intravenous anesthesia in patients with acutely decompensated heart failure undergoing transcatheter aortic valve.pdf
Optimising the post implant care.mp4
Optimising the post implant care.pdf
Optimising treatment for patients in the vulnerable phase.mp4
Optimising treatment for patients in the vulnerable phase.pdf
OPTIMIZE Heart Failure Care Program in Mexico. Impact on early and mid term Heart Failure readmissions.pdf
Optimized medical therapy at admission vs the moment of discharged in patient acute heart failure.pdf
Organisation programme for left ventricular assist device in end stage heart failure patients – Single centre experience.pdf
Outcomes after hospitalization for acute heart failure across regions at different economic levels results from the REPORT-HF registry.mp4
Outcomes after hospitalization for acute heart failure across regions at different economic levels results from the REPORT-HF registry.pdf
Outcomes, survival analysis and the role of kidney damage in modeling the risk of adverse outcome in patients with infective endocarditis.pdf
Oversizing amplatzer device for aortic valve closure in patient with L-VAD, aortic regurgitation and dilated aortic annulus.mp4
Oversizing amplatzer device for aortic valve closure in patient with L-VAD, aortic regurgitation and dilated aortic annulus.pdf
Oxidative sensitivity of sarcomeric titin isoforms gradually decline during cardiac development.pdf
Oxidative stress levels in obese hypertensive patients versus obese normotensive patients.pdf
Palliative care on end-stage heart failure EPICTER Study.pdf
Panel Discussion – Guidelines in Daily Practice II heart failure and hypertension.mp4
Panel discussion – Guidelines in Daily Practice III Myocardial revascularisation in heart failure.mp4
Panel discussion – Guidelines in Daily Practice IV patient with acute heart failure and pulmonary embolism.mp4
Panel discussion – Guidelines in Daily Practice V pregnancy and heart failure.mp4
Panel discussion – HFA Focus -1.mp4
Panel discussion – HFA Focus -2.mp4
Panel Discussion – Iron disorders practical guidance for the clinician.mp4
Panel Discussion – Late breaking trial I – Acute heart failure.mp4
Panel Discussion – Late breaking trial II – Chronic heart failure.mp4
Panel discussion – Making critical choices for patients at the right time.mp4
Panel discussion – Making critical choices for patients at the right time.pdf
Panel discussion – The Grand Debate 2 Challenges in heart failure management mitral regurgitation and atrial fibrillation -1.mp4
Panel discussion – The Grand Debate 2 Challenges in heart failure management mitral regurgitation and atrial fibrillation -2.mp4
Panel discussion – Treatment choices to optimise benefits for heart failure patients.mp4
Panel discussion – Treatment choices to optimise benefits for heart failure patients.pdf
Panel discussion and close – Management of hyperkalaemia in patients with heart failure.pdf
Panel discussion and close – Management of iron deficiency in heart failure implementing best practices to improve patient outcomes.mp4
Panel discussion and close – Management of iron deficiency in heart failure implementing best practices to improve patient outcomes.pdf
Panel discussion and summary – Who should receive the wearable cardioverter defibrillator.mp4
Panel discussion the road ahead.mp4
Pathophysiology and molecular mechanisms.mp4
Pathophysiology and molecular mechanisms.pdf
Pathophysiology _ M Senni (Bergamo,IT).mp4
Pathophysiology _ M Senni (Bergamo,IT).pdf
Pathophysiology _ S Heymans (Maastricht,NL).mp4
Pathophysiology _ S Heymans (Maastricht,NL).pdf
Patient associations in heart failure current status and perspectives.mp4
Patient associations in heart failure current status and perspectives.pdf
Patient involvement in clinical research from design to implementation.mp4
Patient involvement in clinical research from design to implementation.pdf
Patient preferences.mp4
Patient preferences.pdf
Patients in the ESC guidelines the emerging role.mp4
Patients in the ESC guidelines the emerging role.pdf
Patients with CHF at low risk after acute decompensation do not need for careful observation and intensive treatment.pdf
Patients with prosthetic valve endocarditis admitted in non-reference centers may substantially benefit from infectious.pdf
Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and Chronic Kidney Disease (AMBER).mp4
Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and Chronic Kidney Disease (AMBER).pdf
Pattern of anticoagulation therapies in pulmonary embolism in the current era of non antivitamin k anticoagulants (NOACs).pdf
Patterns of access to medical care in acute myocardial infarction.pdf
Performance of an implanted cardiac device heart failure risk predictor, in a real-world tertiary heart failure clinic.pdf
Personalising care for heart failure patients.mp4
Personalising care for heart failure patients.pdf
Pharmacodynamic and pharmacokinetic interaction profile of vericiguat.pdf
Pharmacodynamic interaction study of a long-acting nitrate co-administered with vericiguat in patients with stable coronary.pdf
Pharmacy-based interdisciplinary intervention for patients with chronic heart failure.mp4
Pharmacy-based interdisciplinary intervention for patients with chronic heart failure.pdf
Phenotyping heart failure by biomarkers.mp4
Phenotyping heart failure by biomarkers.pdf
Phoenixin concentration in plasma of heart failure with reduced ejection fraction patients.pdf
Phosphodiesterase 9A – novel biomarker or potential therapeutic target in patients with heart failure and preserved ejection fraction.mp4
Phosphodiesterase 9A – novel biomarker or potential therapeutic target in patients with heart failure and preserved ejection fraction.pdf
Phrenic nerve stimulation.mp4
Phrenic nerve stimulation.pdf
Platelet aggregation test with adenosine diphosphate in prevention of early coronary stent thrombosis.pdf
Polymorphisms in the CYP11B2 and AGT genes related to the renin-angiotensin-aldosterone system and their correlation.pdf
Polypharmacy in patients with chronic heart failure.pdf
Polyserositis post influenza vaccination, presented as acute heart failure.pdf
Population pharmacokinetics and pharmacodynamics of vericiguat in heart failure patients with reduced ejection fraction.pdf
Positioning of the topic _ B Bozkurt (Houston,US).mp4
Positioning of the topic _ B Bozkurt (Houston,US).pdf
Positioning of the topic _ F Ruschitzka (Zurich,CH).mp4
Positioning of the topic _ F Ruschitzka (Zurich,CH).pdf
Positioning of the topic _ G Filippatos (Athens,GR).mp4
Positioning of the topic _ G Filippatos (Athens,GR).pdf
Positioning SLG-2 inhibitors in the treatment of diabetes in heart failure.mp4
Positioning SLG-2 inhibitors in the treatment of diabetes in heart failure.pdf
Post-rest inotropic reaction of the myocardium in dependence on SERCA2a expression level and metabolic enzyme activity.pdf
Potassium binders.mp4
Potassium binders.pdf
Precipitants of admission in heart failure; adherence & alteration of medication by other clinical services pose.pdf
Predicting arrhythmic risk in dilated cardiomyopathy a meta-analysis of clinical parameter.mp4
Predicting arrhythmic risk in dilated cardiomyopathy a meta-analysis of clinical parameter.pdf
Prediction of 30-day readmission for Heart Failure by N-terminal pro-brain natriuretic peptides.pdf
Prediction of dialysis in heart failure patients with diuretic resistance.mp4
Prediction of dialysis in heart failure patients with diuretic resistance.pdf
Prediction of heart failure decompensations using artificial intelligence techniques.pdf
Predictive factors for all cause mortality and readmissions at follow up for patients presented with acute decompensated heart failure.pdf
Predictive utility of high-sensitivity troponin-T for new-onset heart failure is higher in women than in men.mp4
Predictive utility of high-sensitivity troponin-T for new-onset heart failure is higher in women than in men.pdf
Predictors of cognitive impairment in patients with chronic heart failure and reduced left ventricular ejection fraction.pdf
Predictors of heart failure after aortic valve replacement in 2,500 patients.pdf
Predictors of in-hospital mortality in patients with acute coronary syndrome in Kosovo.pdf
Predictors of maximal exercise capacity in long-term mechanical circulatory support.mp4
Predictors of maximal exercise capacity in long-term mechanical circulatory support.pdf
Predictors of mortality in patients with heart failure with mid-range ejection fraction (HFmrEF).pdf
Pregnancy in patients with pre-existing cardiomyopathy and in cardiac transplant patients.pdf
Preliminary experience of remote management of heart failure patients with a multisensor ICD alert.pdf
Pressure monitoring.mp4
Pressure monitoring.pdf
Prevalence and prognostic impact of anaemia, renal insufficiency, and iron deficiency in patients discharged from hospital.pdf
Prevalence of cardiac and non cardiac comorbidities in heart failure outpatients with preserved, mid ranged, and reduced ejection fraction.pdf
Prevalence, clinical features and outcomes of different phenotypes of acute kidney injury in infective endocarditis.pdf
Prevention of cardiotoxicity.mp4
Prevention of cardiotoxicity.pdf
Problem of 30-day readmission for Heart Failure could be improved. Results of IMPEDANCE-HF extended trial.pdf
Prognosis of patients with chronic coronary artery disease undergoing to percutaneous coronary intervention (5 years follow-up).pdf
Prognosis value of the mini nutritional assessment short form tool in outpatients with heart failure with mid-range ejection fraction.pdf
Prognostic impact of comorbidities on mortality and re-hospitalization in acute decompensated heart failure in real world clinical settings.pdf
Prognostic impact of ICD interventions in a real-world primary and secondary prevention population.mp4
Prognostic impact of ICD interventions in a real-world primary and secondary prevention population.pdf
Prognostic impact of MitraClip in patients with left ventricular dysfunction and functional mitral valve regurgitation.pdf
Prognostic nutrition index predicts prognosis in ultra-elderly patients with heart failure.pdf
Prognostic role of diabetes and of medium-term glycemic control in heart failure.pdf
Prognostic role of right ventricular global longitudinal strain in dilated cardiomyopathy.pdf
Prognostic significance of biomarkers in infective endocarditis.pdf
Prognostic significance of obesity after ST-elevation myocardial infarction the impact on heart failure.pdf
Prognostic significance of worsening blood urea nitrogen in patients with acute heart failure.pdf
Prognostic value of baseline and change of NT-proBNP plasma concentrations in pre-capillary pulmonary hypertension.pdf
Prognostic value of bioimpedance vector analysis-assessed cachexia in patients with decompensated heart failure.pdf
Prognostic value of cognitive tests in chronic heart failure with reduced left ventricular ejection fraction.pdf
Prognostic value of handgrip strength in patients with heart failure.pdf
Programing of the device, brady vs tachy.mp4
Programing of the device, brady vs tachy.pdf
Prolonged mechanical ventilation after left ventricular assist-device implantation risk factors and clinical implications.pdf
Prospective evaluation of natriuretic peptide based referral of chronic heart failure patients in primary care (PREFER).mp4
Prospective evaluation of natriuretic peptide based referral of chronic heart failure patients in primary care (PREFER).pdf
Psychosocial and educational interventions to combat frailty.mp4
Psychosocial and educational interventions to combat frailty.pdf
Pulmonary arterial hypertension associated with corrected CHD vs Eisenmenger syndrome.pdf
Pulmonary arterial hypertension treatment in latin america.pdf
Pulmonary embolism.mp4
Pulmonary embolism.pdf
Pulmonary thromboembolism in the patient with single ventricle id type and opening kava-caval collaterals.pdf
Purified exosome product and extracellular vesicles treatment for acute myocarditis, dilated cardiomyopathy and heart failure.mp4
Purified exosome product and extracellular vesicles treatment for acute myocarditis, dilated cardiomyopathy and heart failure.pdf
QRS dispersion in dilated cardiomyopathy, clinical and echocardiographic correlations.pdf
Quality of heart failure treatment treated by residential cardiologists -The HeartFailureBavaria Project.pdf
R wave sensed from the left ventricle as mortality predictor in patients with cardiac resynchronization therapy for primary prevention.pdf
Rapid recovery of myocardial dysfunction in an oncologic patient.pdf
Rare cause of acute heart failure in a young patient.pdf
RBM20 missense variant presenting as acute myocarditis and postpartum cardiomyopathy.pdf
Reassuring community heart failure care in the absence of specialist involvement; but some gaps indicate need for continued.pdf
Recent epidemiologic data HFA advanced centers map.mp4
Recent epidemiologic data HFA advanced centers map.pdf
Recognition of risk factors and symptoms of acute myocardial infarction.pdf
Recovery of heart failure due to severe malnutrition and marked electrolyte abnormalities.pdf
Red cell distribution width potential biomarker of the risk of right ventricular involvement in systemic sclerosis.pdf
Reduced mitochondrial aldehyde dehydrogenase-2 activity and protein levels in left ventricular myocardium of dogs with Heart Failure.pdf
Reduction of Mitral Regurgitation in Patients with Heart Failure and Secondary Mitral Regurgitation.mp4
Reduction of Mitral Regurgitation in Patients with Heart Failure and Secondary Mitral Regurgitation.pdf
Reduction of NT-proBNP in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction.pdf
Regional differences in characteristics and correlates of coronary microvascular dysfunction in HFpEF.pdf
Registry of Severe Acute Heart Failure. Impact of Renal Insufficiency for In-Hospital Mortality and Readmissions.pdf
Relationship between diastolic dysfunction and cognitive impairment in patients with CAD and HFpEF.pdf
Relationship of genetic determination of peripartum cardiomyopathy to its clinical outcome.pdf
Renal denervation.mp4
Renal denervation.pdf
Renal dysfunction classification and epidemiology.mp4
Renal dysfunction classification and epidemiology.pdf
Renal function and electrolyte assays in patients with heart failure – a comparison between patients with reduced.pdf
Renin-angiotensin-aldosterone system inhibition.mp4
Renin-angiotensin-aldosterone system inhibition.pdf
Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period.mp4
Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period.pdf
Rericarditis in heart failure. To treat or not.mp4
Rericarditis in heart failure. To treat or not.pdf
Residual congestion on discharge for Heart Failure assessed by impedance technique predicts 30-day and one-year All-cause death.pdf
Residual congestion on discharge for Heart Failure assessed by impedance technique predicts 30-day and one-year Heart Failure death.pdf
Response rate to sacubitril-valsartan in the community. Is there a clear phenotype.pdf
Rest myocardial perfusion defects are related to increased 99mTc-sestamibi washout and inflammation in CCC.pdf
Restrictive and infiltrative cardiomyopathy amyloidosis and sarcoidosis.mp4
Restrictive and infiltrative cardiomyopathy amyloidosis and sarcoidosis.pdf
Restrictive cardiomyopathy and anomalous origin of the right coronary artery in a patient with desmin- and myotilin-gene variants.mp4
Restrictive cardiomyopathy and anomalous origin of the right coronary artery in a patient with desmin- and myotilin-gene variants.pdf
Reversal of pulmonary hypertension with sacubitril-valsartan in a candidate to heart transplantation.pdf
Reversible left bundle branch block after sacubitril valsartan in patient with severe heart failure.pdf
Revisiting the obesity paradox in heart failure percent body fat as predictor of biomarkers and outcome.pdf
Right heart failure in basedow-graves disease a tricky diagnosis.pdf
Right heart failure related to diffuse large b cell lymphoma.pdf
Risk of readmission and death in patients admitted with new-onset versus worsening heart failure.mp4
Risk of readmission and death in patients admitted with new-onset versus worsening heart failure.pdf
Risk of stroke in patients with chronic heart failure and sinus rhythm.mp4
Risk of stroke in patients with chronic heart failure and sinus rhythm.pdf
Risk stratification _ O Miro (Barcelona,ES).mp4
Risk stratification _ O Miro (Barcelona,ES).pdf
Risk stratification _ V Harjola (Helsinki,FI).mp4
Risk stratification _ V Harjola (Helsinki,FI).pdf
Risks of death from decompensation and cardiovascular causes in patients with chronic heart failure, depending on adherence.pdf
Rivaroxaban and stroke events in patients with heart failure, sinus rhythm, and coronary disease the COMMANDER-HF trial.mp4
Rivaroxaban and stroke events in patients with heart failure, sinus rhythm, and coronary disease the COMMANDER-HF trial.pdf
Role of arrhythmias.mp4
Role of arrhythmias.pdf
Role of cardiac resynchronization therapy in optimizing the recovery of left ventricular function in a patient with peripartum.pdf
Sacubitril Valsartan and SGLT2i a safe combination.pdf
Sacubitril valsartan eligibility and outcomes in the ESC HFA EORP Heart Failure Long-Term Registry.mp4
Sacubitril valsartan eligibility and outcomes in the ESC HFA EORP Heart Failure Long-Term Registry.pdf
Sacubitril valsartan in chronic symptomatic heart failure a real world experience of delivery and outcomes.pdf
Sacubitril Valsartan in clinical practice, how does it work.pdf
Sacubitril Valsartan use in a real world experience data from a large single-center population of heart failure patients.pdf
Sacubitril valsartan _ P Seferovic (Belgrade,RS).mp4
Sacubitril valsartan _ P Seferovic (Belgrade,RS).pdf
Sacubitril Valsartan _ S Solomon (Boston,US).mp4
Sacubitril Valsartan _ S Solomon (Boston,US).pdf
Sacubitril-valsartan and its effect on ventricular remodeling.pdf
Sacubitril-valsartan treatment furtherly improves response to intermittent parenteral levosimendan in ambulatory patients.pdf
Safety and Efficacy of 24-hour Istaroxime Infusion in Patients Hospitalized for Acute Decompensated Heart Failure.mp4
Safety and Efficacy of 24-hour Istaroxime Infusion in Patients Hospitalized for Acute Decompensated Heart Failure.pdf
Safety, pharmacodynamic and pharmacokinetic characterisation of vericiguat key results from six phase I studies in healthy subjects.pdf
Safety, tolerability and discontinuation causes of sacubitril valsartan treatment in patients with heart failure.pdf
Serial change of Layer-specific myocardial functionby Chemotherapy in Breast cancer patients.mp4
Serial change of Layer-specific myocardial functionby Chemotherapy in Breast cancer patients.pdf
Series of patients treated with sacubitril-valsartan in a cardiology day clinic efficacy and safety after 6 months of follow-up.pdf
Serum endotrophin levels in heart failure patients with reduced ejection fraction; a preliminary study.mp4
Serum endotrophin levels in heart failure patients with reduced ejection fraction; a preliminary study.pdf
Serum uric acid levels and xanthine oxidase activity in chronic heart failure patients with chronic kidney disease.pdf
Service quality in a heart failure clinic a comparison analysis to a general cardiology clinic.pdf
Sex differences in optimal doses of heart failure medication.mp4
Sex differences in optimal doses of heart failure medication.pdf
Sex-based differences in heart failure across the ejection fraction spectrum phenotyping, prognostic and therapeutic implications.pdf
Sex-related differences in inflammation-associated biomarkers and their predictive utility for new-onset heart failure.pdf
Sex-specific biomarker profiles underlying Heart Failure development a sub-study of the HOMAGE (Heart OMics in AGEing) consortium.pdf
sGC stimulators.mp4
sGC stimulators.pdf
SGLT-2 inhibitors and cardiac metabolism.mp4
SGLT-2 inhibitors and cardiac metabolism.pdf
SGLT-2 inhibitors.mp4
SGLT-2 inhibitors.pdf
Short and long-term outcomes after radiofrequency catheter ablation of the his bundle the experience of a tertiary center.pdf
Short and medium-term safety and tolerability of Sacubitril-Valsartan and Empaglifozin joint intake.pdf
Short and mid-term prognosis of acutely decompensated heart failure by clinical scenarios on admission.pdf
Short term LV unloading.mp4
Short term LV unloading.pdf
Short term RV unloading.mp4
Short term RV unloading.pdf
Short-term mortality in final stage heart failure patients.pdf
Significance of left ventricular pronounced trabeculations in a patient with recurrent decompensated heart failure.pdf
Significant reduction of insulin dose after administration of sacubitril valsartan in the patient with heart failure.pdf
Significant underutilization of angiotensin receptor neprolysin inhibitor (ARNI) and other evidence-based heart failure (HF).pdf
Single lead implantable cardioverter-defibrillator lead system with a atrial sensing dipole (Dx-AICD technology) 1-year follow-up.pdf
Sleep disordered breathing in patients with heart failure association with biomarkers and clinical parameters.pdf
Slow and steady wins the race- the managment of tachycardia induced cardiomyopathy.pdf
Smart device algorithms to increase CRT response latest clinical evidence.mp4
Smart device algorithms to increase CRT response latest clinical evidence.pdf
Sodium restriction in heart failure take it with a grain of salt.mp4
Sodium restriction in heart failure take it with a grain of salt.pdf
Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with heart failure.pdf
Soluble suppression of tumorigenicity-2 in cardiac amyloidosis, hypertrophic and dilated cardiomyopathy.mp4
Soluble suppression of tumorigenicity-2 in cardiac amyloidosis, hypertrophic and dilated cardiomyopathy.pdf
Specific pattern of cardiopulmonary exercise testing in patients with right heart failure.mp4
Specific pattern of cardiopulmonary exercise testing in patients with right heart failure.pdf
Splanchnic nerve blockade in chronic heart failure (Splanchnic HF-2).mp4
Splanchnic nerve blockade in chronic heart failure (Splanchnic HF-2).pdf
STADE-HF A Titration based on sST2 is safe but failed to decrease readmissions in patients admitted for acute heart failure.pdf
Sterol metabolism is differentially regulated in human induced pluripotent stem cell-derived cardiomyocytes of peripartum.mp4
Sterol metabolism is differentially regulated in human induced pluripotent stem cell-derived cardiomyocytes of peripartum.pdf
Strain analysis reveals subtle systolic dysfunction in ‘confirmed’ and ‘suspected’ myocarditis with normal LVEF.pdf
Stroke.mp4
Stroke.pdf
Subclinical right ventricular dysfunction in gestational hypertension as compared to a normotensive pregnancy group.pdf
Subsequent pregnancies and treatment options.mp4
Subsequent pregnancies and treatment options.pdf
Sudden cardiac death a case of fulminant myocarditis.mp4
Sudden cardiac death a case of fulminant myocarditis.pdf
Sudden cardiac death in a patient with complicated peripartum cardiomyopathy and long QT syndrome.pdf
Summary and conclusion – Treatment choices to optimise benefits for heart failure patients.mp4
Summary and conclusion – Treatment choices to optimise benefits for heart failure patients.pdf
Summary and conclusions – An update on device technologies in heart failure.mp4
Summary and conclusions – An update on device technologies in heart failure.pdf
Surface respiratory electromyography and dyspnea in acute heart failure patients.pdf
Swallow syncope a review of the current evidences.pdf
Sympathetic Renal denervation in patients with refractory arterial hypertension 2-years follow-up.pdf
Tacrolimus and neoplasia. Do level really be important.pdf
Taking care of stroke.mp4
Taking care of stroke.pdf
Taking your time in the treatment of newly diagnosed heart failure patients.mp4
Taking your time in the treatment of newly diagnosed heart failure patients.pdf
Takotsubo syndrome complicated by left ventricular outflow tract obstruction in a woman with chronic beta-blocker therapy.pdf
Takotsubo syndrome masking apical hypertrophic cardiomyopathy.pdf
Takotsubo-like syndrome in a patient with BRAF mutated metastatic lung cancer.pdf
Targeting cardiac amyloidosis.mp4
Targeting cardiac amyloidosis.pdf
Targeting the cellular origin of cardiac fibrosis.mp4
Targeting the cellular origin of cardiac fibrosis.pdf
TAVI should be used in low risk patients with symptomatic severe aortic stenosi – Rebuttal.mp4
TAVI should be used in low risk patients with symptomatic severe aortic stenosis – Con.mp4
TAVI should be used in low risk patients with symptomatic severe aortic stenosis – Con.pdf
TAVI should be used in low risk patients with symptomatic severe aortic stenosis – Pro.mp4
TAVI should be used in low risk patients with symptomatic severe aortic stenosis – Pro.pdf
Team Presentation.mp4
Team Presentation.pdf
Telemonitoring how to avoid re-hospitalisation.mp4
Telemonitoring how to avoid re-hospitalisation.pdf
Telemonitoring in heart failiure.mp4
Telemonitoring in heart failiure.pdf
Temporal improvement in CRT response and survival a review of multicenter trials.mp4
Temporal improvement in CRT response and survival a review of multicenter trials.pdf
The 6-min walk test in assessment for mortality in patients with heart failure.pdf
The adherence to pharmacological treatment in patients with chronic heart failure.pdf
The altered expression of autophagy-related genes participates in heart failure.pdf
The blood levels of apelin and angiotensin-(1-7) and their interrelations with parameters of left ventricular.pdf
The cardiologist perspective on GLP-1 receptor agonist and DPP-4 inhibitors.mp4
The cardiologist perspective on GLP-1 receptor agonist and DPP-4 inhibitors.pdf
The characteristics of electrocardiographic markers of sudden cardiac death (SCD) in recovery peripartum cardiomyopathy patients.pdf
The clinical case of successful treatment of heart failure due to tachycardia-induced cardiomyopathy in a patient with paroxysmal atrial flutter.pdf
The clinical significance of interleukin-6 in heart failure results from the BIOSTAT-CHF study.pdf
The combined use of left ventricular assist device and extracorporeal membrane oxygenation in a patient with severe heart failure.mp4
The combined use of left ventricular assist device and extracorporeal membrane oxygenation in a patient with severe heart failure.pdf
The crucial role of the heart valve team in the management of a complex case of multivalvular disease and heart failure.pdf
The definition of left bundle branch block and non-specific intraventricular conduction delay influences long-term mortality.pdf
The detrimental effect of right atrial pacing on left atrial function and clinical outcome in cardiac resynchronization therapy.mp4
The detrimental effect of right atrial pacing on left atrial function and clinical outcome in cardiac resynchronization therapy.pdf
The Dutch multidisciplinary guideline ‘Palliative care for patients with heart failure’.pdf
The dynamics of quality of life in patients with congestive heart failure according to cardiac resynchronisation therapy response.pdf
The effect of CPAP and oral appliances treatment on biomarkers in patients with heart failure and OSA.pdf
The effect of liraglutide on natriuretic peptides and copeptin in heart failure patients.mp4
The effect of liraglutide on natriuretic peptides and copeptin in heart failure patients.pdf
The effect of prehospital diuretic administration on clinical outcomes in patients with acute heart failure.pdf
The effects of long-term treatment with sympathetic nervous system blockers on diastolic function in patients with resistant hypertension.pdf
The effects of phrenic nerve stimulation on heart rate variability a case study.pdf
The efficacy of ‘Get With the Guidelines Heart Failure,’ a retrospective analysis.pdf
The efficacy of nicorandil for patients with ischemic chronic heart failure.pdf
The electrocardiographic markers of sudden cardiac death (SCD) and left ventricular global longitudinal strain in recovery peripartum.pdf
The ESC HF long-term EORP registry impact on clinical practice.mp4
The ESC HF long-term EORP registry impact on clinical practice.pdf
The extracellular matrix does it all.mp4
The extracellular matrix does it all.pdf
The follow-up of patients with chronic heart failure and implantable cardioverter defibrillator in primary prevention.pdf
The HFA Eugene Braunwald lecture Is Heart Failure a curable disease.mp4
The HFA Eugene Braunwald lecture Is Heart Failure a curable disease.pdf
The HFA Philip Poole Wilson lecture Introduction of M. Jessup.mp4
The HFA Philip Poole Wilson lecture Introduction of M. Jessup.pdf
The hurdlers and perspectives of heart transplantation.mp4
The hurdlers and perspectives of heart transplantation.pdf
The immunosupressive drugs.mp4
The immunosupressive drugs.pdf
The impact of coronary sinus reducer on left ventricular function in patients with refractory angina; new horizons in ischemic cardiomyopathy.pdf
The impact of extracorporeal photopheresis on peripheral blood leukocyte subclasses in heart transplant recipients.pdf
The impact of patients adherence to the lifestyle advice on all-cause mortality in patients with heart failure.pdf
The impact of prior ejection fraction on clinical outcomes in patients with heart failure with mid-range ejection fraction.pdf
The impact of short term amiodarone treatment on hsCRP level in patients with ischemic heart failure and paroxysmal atrial fibrillation.pdf
The impact of the use of sacubitril valsartan on clinical and echocardiographic parameters in heart failure patients.pdf
The impact of the WCD for patients who choose to wear it.mp4
The impact of the WCD for patients who choose to wear it.pdf
The importance of optimal dosing of ferric-carboxymaltose to treat iron deficiency.mp4
The importance of optimal dosing of ferric-carboxymaltose to treat iron deficiency.pdf
The influence of diabetes mellitus on outcomes in patients with acute heart failure.pdf
The left ventricular noncompaction and hypertrabecularity in adult patients clinical classification and follow-up.pdf
The long-term prognosis of patients with different types of heart failure admitted with decompensation in Russia.pdf
The new clinical tool of severity assessment in elderly patients with heart failure.pdf
The omega phase dilemmas and devices.mp4
The omega phase dilemmas and devices.pdf
The patient journey of heart failure patients in Belgian hospitals.pdf
The place of telemedicine in the management of heart failure in community medicine.pdf
The prevalence of elevated heart rate in oncology patients a risk factor revisited.pdf
The price of emulating Hercules mephentermine associated cardiomyopathy (MAC).mp4
The price of emulating Hercules mephentermine associated cardiomyopathy (MAC).pdf
The prognosis of patients with chronic heart failure, depending on adherence to observation in a specialized heart failure treatment center.pdf
The ratio of fibroblast growth factor 23 to phosphorus as a predictor of cardiovascular death in heart failure patients with reduced ejection.pdf
The register of pericarditis in the university therapeutic clinic nosological spectrum, approaches to diagnosis and treatment.pdf
The relationship between hemoconcentration during hospitalization and outcomes in patients hospitalized for acute heart failure.pdf
The relationship of sympathetic regulation with immune inflammation, fibrosis, neurohumoral activation in patients.pdf
The risk of bias of current novel circulating biomarker studies for the detection of HFpEF and left ventricular diastolic dysfunction.mp4
The risk of bias of current novel circulating biomarker studies for the detection of HFpEF and left ventricular diastolic dysfunction.pdf
The role of endomyocardial biopsy in clinical decision making.mp4
The role of endomyocardial biopsy in clinical decision making.pdf
The role of hyperuricemia in the progression of chronic heart failure in patients with arterial hypertension.pdf
The role of inflammation and fibrosis in the occurrence of atrial fibrillation in heart failure patients with mid-range ejection fraction.pdf
The role of NIV.mp4
The role of NIV.pdf
The role of statins in heart failure.mp4
The role of statins in heart failure.pdf
The secreted matrix glycoprotein ADAMTSL3 is up-regulated in heart failure and mediates anti-fibrotic effects in cardiac fibroblasts.pdf
The significance of plasma osmolarity for in-hospital course and long-term outcome in patients with acute heart failure.pdf
The superimposed myocarditis in arrhythmogenic right ventricular cardiomyopathy.pdf
The utility of the MAGGIC heart failure risk score in predicting response to spironolactone validation and results from the TOPCAT trial.pdf
The value of discharge bio-ADM as a marker of residual congestion, discharge loop diuretic doses and clinical outcomes in patients.mp4
The value of discharge bio-ADM as a marker of residual congestion, discharge loop diuretic doses and clinical outcomes in patients.pdf
The value of tubular maximum phosphate reabsorption capacity, a functional proximal tubular parameter in heart failure.mp4
The value of tubular maximum phosphate reabsorption capacity, a functional proximal tubular parameter in heart failure.pdf
Therapeutic advances for patients with heart failure and diabetes.mp4
Therapeutic advances for patients with heart failure and diabetes.pdf
Therapeutic options.mp4
Therapeutic options.pdf
Therapeutic synergy between drugs, devices and interventions.mp4
Therapeutic synergy between drugs, devices and interventions.pdf
Therapy with Sacubitril-Valsartan should begin in hospital – Con.mp4
Therapy with Sacubitril-Valsartan should begin in hospital – Con.pdf
Therapy with Sacubitril-Valsartan should begin in hospital – Rebuttal.mp4
Therapy with Sacubitril-Valsartan should begin in hospital-Pro.mp4
Therapy with Sacubitril-Valsartan should begin in hospital-Pro.pdf
Thirst distress in heart failure outpatients in a Spanish cohort.pdf
Thirty day and one-year risk stratification of Heart Failure Death According N-terminal pro-brain natriuretic peptide.pdf
Timing of echocardiographic evaluation of patients with advanced heart failure. Is it time consuming.pdf
Titration process and predictors of achieving target dose of sacubitril valsartan in patients with chronic heart failure.pdf
To evaluate the safety and tolerability of ARNI initiation in inpatient versus outpatient setting in an Asian population a real world study.pdf
Tracking and tailoring exercice at home.mp4
Training frail patients with heart failure mission impossible.mp4
Training frail patients with heart failure mission impossible.pdf
Transcatheter aortic valve replacement in patients with aortic stenosis and mitral regurgitation.pdf
Transcatheter mitral interventions indications and controversies.mp4
Transcatheter mitral interventions indications and controversies.pdf
Transcatheter Mitral-Valve Repair in patients with heart failure and severe dysfunction.mp4
Transcatheter Mitral-Valve Repair in patients with heart failure and severe dysfunction.pdf
Trastuzumab associated cardiotoxicity in breast cancer patients a report after 4 years of follow up at a specialized centre.pdf
Treasurer’s Report.mp4
Treasurer’s Report.pdf
Treating diabetes saves the heart.mp4
Treating diabetes saves the heart.pdf
Treatment challenges in HFpEF.mp4
Treatment challenges in HFpEF.pdf
Treatment of central sleep apnoea with phrenic nerve stimulation is associated with reduction in heart failure-related hospitalizations.mp4
Treatment of central sleep apnoea with phrenic nerve stimulation is associated with reduction in heart failure-related hospitalizations.pdf
Treatment of inflammation in heart failure.mp4
Treatment of inflammation in heart failure.pdf
Treatment of obstructive sleep apnea from masks to neurostimulation.mp4
Treatment of obstructive sleep apnea from masks to neurostimulation.pdf
Treatment of patients with chronic heart failure.pdf
Treatment of type 2 diabetes with without heart failure pending results from ongoing trials.pdf
Treatment of type 2 diabetes with-without heart failure pending results from ongoing trials.mp4
Treatment options for central sleep apnea.mp4
Treatment options for central sleep apnea.pdf
Treatment options for decongestion.mp4
Treatment options for decongestion.pdf
Tricuspid regurgitation. Is there any place for intervention.mp4
Tweet or not tweet.mp4
Tweet or not tweet.pdf
Type 2 diabetes is a strong predictor of mortality in patients with prosthetic valve endocarditis with or without heart failure.pdf
Uncontrolled hypertensives with heart failure with preserved ejection fraction-adherence to therapy.pdf
Uncovering the aetiology of heart failure cardiac CT.mp4
Uncovering the aetiology of heart failure cardiac CT.pdf
Understanding the contemporary use of thiazolidinediones. An analysis of the Diabetes Collaborative Registry.pdf
Unexpected loss in advanced heart failure.mp4
Unexpected loss in advanced heart failure.pdf
Up-to-date indications and proper timing.mp4
Up-to-date indications and proper timing.pdf
Update on devices from HFA workshop 2019.mp4
Update on devices from HFA workshop 2019.pdf
Updated treatment algorithm in advanced heart failure.mp4
Updated treatment algorithm in advanced heart failure.pdf
Use of anabolics and appetite stimulants.mp4
Use of anabolics and appetite stimulants.pdf
Use of aspirin as primary prevention prior to an acute coronary syndrome.pdf
Use of exercise and devices.mp4
Use of exercise and devices.pdf
Use of sacubitril-valsartan in elderly patients. Subanalysis of the SAVE-RLife study.pdf
Use of wearables and clinical decision support tools for monitoring heart failure patients.mp4
Use of wearables and clinical decision support tools for monitoring heart failure patients.pdf
Usefulness of balloom aortic valvuloplasty in the management of patients with aortic stenosis.pdf
Usefulness of global longitudinal strain as predictor for sub-clinical left ventricular dysfunction and all-cause mortality among active.pdf
Using cardiovascular magnetic resonance imaging to improve classification of ejection fraction.pdf
Using large-scale real-world data to evaluate treatment strategies and guide future clinical trial design pitfalls and opportunities.mp4
Using large-scale real-world data to evaluate treatment strategies and guide future clinical trial design pitfalls and opportunities.pdf
Utility of the ultrasound.mp4
Utility of the ultrasound.pdf
V-slope as a marker of multivessel disease in the ergometry with oxygen consumption.pdf
Vaccination uptake in HF patients; identifying a critical gap of care.pdf
Validation of the ELAN HF model and selfcare behaviour in patients with acute decompensated heartfailure.mp4
Validation of the ELAN HF model and selfcare behaviour in patients with acute decompensated heartfailure.pdf
Vasodilators from guidelines to practice.mp4
Vasodilators from guidelines to practice.pdf
Venovenous ECMO as a rescue tool in acute respiratory failure during LVAD implantation in a patient with Cardiogenic Shock.mp4
Venovenous ECMO as a rescue tool in acute respiratory failure during LVAD implantation in a patient with Cardiogenic Shock.pdf
Ventricular assist device wireless energy transfer.mp4
Ventricular assist device wireless energy transfer.pdf
Ventricular function recovery in chronic heart failure patients.pdf
Ventricular hypertrophy in a family with sarcomeric hypertrophic cardiomyopathy always of genetic origin.mp4
Ventricular hypertrophy in a family with sarcomeric hypertrophic cardiomyopathy always of genetic origin.pdf
Ventricular reshaping targeting the ventricle and the annulus.mp4
Ventricular reshaping targeting the ventricle and the annulus.pdf
Vericiguat.mp4
Viruses innocent bystanders.mp4
Viruses innocent bystanders.pdf
Vitamin D deficiency and treatment impact in major outcomes and functional capacity in heart failure patients.pdf
Vive la difference Europe vs America – Discussion.mp4
Vive la difference Europe vs America.mp4
Vive la difference Europe vs America.pdf
VO2 recovery delay is a useful predictor for impaired recovery of left ventricular function in heart failure with reduced ejection fraction.pdf
We don’t always need the defibrillator – Contra.mp4
We don’t always need the defibrillator – Contra.pdf
We don’t always need the defibrillator – Pro.mp4
We don’t always need the defibrillator – Pro.pdf
We don’t always need the defibrillator – Rebuttal.mp4
Wearable defibrillator for the prevention of sudden cardiac death our preliminary experience.pdf
Welcome and introduction – Management of hyperkalaemia in patients with heart failure.mp4
Welcome and introduction – Management of hyperkalaemia in patients with heart failure.pdf
Welcome and introduction – Management of iron deficiency in heart failure implementing best practices to improve patient outcomes.mp4
Welcome and introduction – Management of iron deficiency in heart failure implementing best practices to improve patient outcomes.pdf
Welcome and introduction – Treatment choices to optimise benefits for heart failure patients.mp4
Welcome and introduction – Treatment choices to optimise benefits for heart failure patients.pdf
Welcome from the President-Elect of the ESC.mp4
Welcome from the President-Elect of the ESC.pdf
Welcome to Heart Failure 2019 & World Congress on Acute Heart Failure.mp4
Welcome to Heart Failure 2019 & World Congress on Acute Heart Failure.pdf
Welcome video.mp4
Welcome video.pdf
What can we learn from COAPT trial.mp4
What can we learn from COAPT trial.pdf
What do the guidelines say _ J Bauersachs (Hannover,DE).mp4
What do the guidelines say _ J Bauersachs (Hannover,DE).pdf
What do the guidelines say _ M Sousa Uva (Carnaxide,PT).mp4
What do the guidelines say _ M Sousa Uva (Carnaxide,PT).pdf
What do the guidelines say _ S Anker (Berlin,DE).mp4
What do the guidelines say _ S Anker (Berlin,DE).pdf
What do the guidelines say _ SV Konstantinides (Mainz,DE).mp4
What do the guidelines say _ SV Konstantinides (Mainz,DE).pdf
What do the guidelines say _ T McDonagh (London,GB).mp4
What do the guidelines say _ T McDonagh (London,GB).pdf
What imaging techniques do you need.mp4
What imaging techniques do you need.pdf
When the surgeon should step in.mp4
When the surgeon should step in.pdf
Wild type TTR amyloidosis disguised as concentric hypertensive left ventricular hypertrophy.pdf
Women in heart failure clinical trials.mp4
Women in heart failure clinical trials.pdf
Young computer-literate health care professionals have the greatest expectations for heart failure telemonitoring.pdf

Reviews

There are no reviews yet.

Be the first to review “European Society of Cardiology Heart Failure 2019”

Your email address will not be published.